CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | sulindac |
|
Accession: | CHEBI:9352
|
browse the term
|
Definition: | A monocarboxylic acid that is 1-benzylidene-1H-indene which is substituted at positions 2, 3, and 5 by methyl, carboxymethyl, and fluorine respectively, and in which the phenyl group of the benzylidene moiety is substituted at the para position by a methylsulfinyl group. It is a prodrug for the corresponding sulfide, a non-steroidal anti-inflammatory drug, used particularly in the treatment of acute and chronic inflammatory conditions. |
Synonyms: | exact_synonym: | {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid |
| related_synonym: | (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; Clinoril; Formula=C20H17FO3S; InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-; InChIKey=MLKXDPUZXIRXEP-MFOYZWKCSA-N; SMILES=CC1=C(CC(O)=O)c2cc(F)ccc2C\\1=C/c1ccc(cc1)S(C)=O; Sulindacum; cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid; sulindaco |
| xref: | Beilstein:2951842; CAS:38194-50-2; DrugBank:DB00605; Drug_Central:2534; HMDB:HMDB0014743; KEGG:C01531; KEGG:D00120 |
| xref_mesh: | MESH:D013467 |
| xref: | PDBeChem:SUZ; PMID:11569947; PMID:11927004; PMID:12406542; PMID:15020200; PMID:15123337; PMID:19884509; PMID:23689354; PMID:23804703; Patent:DE2039426; Patent:US3654349; Reaxys:2951842; Wikipedia:Sulindac |
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression multiple interactions |
ISO |
Sulindac results in increased expression of ABCC1 protein Acetylcysteine inhibits the reaction [Sulindac results in increased expression of ABCC1 protein] |
CTD |
PMID:11820781 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Sulindac results in increased expression of ABCC3 protein] |
CTD |
PMID:11820781 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcd3 |
ATP binding cassette subfamily D member 3 |
increases expression |
EXP |
Sulindac results in increased expression of ABCD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020
|
|
G |
Abhd16a |
abhydrolase domain containing 16A, phospholipase |
increases expression |
EXP |
Sulindac results in increased expression of ABHD16A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:3,719,089...3,733,952
Ensembl chr20:3,719,091...3,733,927
|
|
G |
Abi1 |
abl-interactor 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of ABI1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:85,098,837...85,179,829
Ensembl chr17:85,098,550...85,179,792
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
increases expression |
ISO |
Sulindac results in increased expression of ACACA mRNA |
CTD |
PMID:32535746 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acad9 |
acyl-CoA dehydrogenase family, member 9 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ACAD9 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
decreases expression |
ISO EXP |
Sulindac results in decreased expression of ACE2 mRNA |
CTD |
PMID:32808185 |
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Acly |
ATP citrate lyase |
increases expression |
ISO |
Sulindac results in increased expression of ACLY mRNA |
CTD |
PMID:32535746 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Acp2 |
acid phosphatase 2, lysosomal |
increases expression |
ISO |
Sulindac results in increased expression of ACP2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 3:77,175,022...77,185,180
Ensembl chr 3:77,175,895...77,185,680
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ACSL1 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Actr10 |
actin related protein 10 |
decreases expression |
EXP |
Sulindac results in decreased expression of ACTR10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:89,446,141...89,472,350
Ensembl chr 6:89,446,093...89,473,047
|
|
G |
Acy1 |
aminoacylase 1 |
increases expression |
EXP |
Sulindac results in increased expression of ACY1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Add1 |
adducin 1 |
increases expression |
EXP |
Sulindac results in increased expression of ADD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182
|
|
G |
Adhfe1 |
alcohol dehydrogenase, iron containing, 1 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ADHFE1 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517
|
|
G |
Adipor2 |
adiponectin receptor 2 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ADIPOR2 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adss2 |
adenylosuccinate synthase 2 |
increases expression |
EXP |
Sulindac results in increased expression of ADSS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:89,769,240...89,799,577
Ensembl chr13:89,769,244...89,799,604
|
|
G |
Agfg2 |
ArfGAP with FG repeats 2 |
increases expression |
EXP |
Sulindac results in increased expression of CCZ1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:19,012,228...19,048,433
Ensembl chr12:19,012,258...19,048,421
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases localization multiple interactions |
ISO EXP |
Sulindac results in increased localization of AHR protein Sulindac binds to and results in increased activity of AHR protein |
CTD |
PMID:16531450 PMID:17985343 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aif1l |
allograft inflammatory factor 1-like |
decreases expression |
ISO |
Sulindac results in decreased expression of AIF1L mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 3:15,229,476...15,254,033
Ensembl chr 3:15,229,524...15,254,023
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
affects localization |
ISO |
Sulindac affects the localization of AIFM1 protein |
CTD |
PMID:15946692 PMID:17136320 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Aifm2 |
AIF family member 2 |
increases expression |
ISO |
Sulindac results in increased expression of AIFM2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr20:29,654,283...29,679,239
Ensembl chr20:29,652,927...29,679,236
|
|
G |
Akap1 |
A-kinase anchoring protein 1 |
increases expression |
EXP |
Sulindac results in increased expression of AKAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:73,621,021...73,654,123
Ensembl chr10:73,621,883...73,653,896
|
|
G |
Akap9 |
A-kinase anchoring protein 9 |
decreases expression |
EXP |
Sulindac results in decreased expression of AKAP9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
multiple interactions |
ISO |
Sulindac analog binds to and results in decreased activity of AKR1B1 protein; Sulindac binds to and results in decreased activity of AKR1B1 protein |
CTD |
PMID:25532697 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
multiple interactions |
ISO |
Sulindac analog binds to and results in decreased activity of AKR1B10 protein; Sulindac binds to and results in decreased activity of AKR1B10 protein |
CTD |
PMID:25532697 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases activity |
ISO |
Sulindac results in decreased activity of AKR1C1 protein |
CTD |
PMID:19010312 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
decreases activity |
ISO |
Sulindac results in decreased activity of AKR1C2 protein |
CTD |
PMID:19010312 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
decreases activity |
ISO |
Sulindac results in decreased activity of AKR1C3 protein |
CTD |
PMID:19010312 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO EXP |
[AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein]] which affects the susceptibility to Oxygen; AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein] Sulindac analog results in decreased phosphorylation of AKT1 protein [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of AKT1 mRNA |
CTD |
PMID:18924134 PMID:20371263 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt1s1 |
AKT1 substrate 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of AKT1S1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:95,333,186...95,339,678
Ensembl chr 1:95,332,898...95,339,677
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
decreases expression increases expression |
ISO EXP |
Sulindac results in decreased expression of AKT2 mRNA Sulindac results in increased expression of AKT2 mRNA |
CTD |
PMID:11906190 PMID:24136188 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Alb |
albumin |
multiple interactions |
EXP |
[Sulindac co-treated with REN2] results in increased expression of ALB protein |
CTD |
PMID:12586211 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ALDH1A1 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ALDH1L1 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
decreases expression |
EXP |
Sulindac results in decreased expression of ALDH3A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ALDH6A1 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Alg14 |
ALG14, UDP-N-acetylglucosaminyltransferase subunit |
increases expression |
EXP |
Sulindac results in increased expression of ALG14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:209,368,285...209,445,425
Ensembl chr 2:209,368,312...209,445,431
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
increases expression increases activity multiple interactions |
ISO |
Sulindac results in increased expression of ALOX15 protein Sulindac results in increased activity of ALOX15 protein [Sulindac results in increased expression of ALOX15 protein] which results in increased chemical synthesis of 13-hydroxy-9,11-octadecadienoic acid |
CTD |
PMID:10904086 PMID:11406566 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
ISO |
Sulindac promotes the reaction [cobaltous chloride results in decreased expression of ALPL protein]; Sulindac promotes the reaction [Deferoxamine results in decreased expression of ALPL protein] |
CTD |
PMID:21882223 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Amd1 |
adenosylmethionine decarboxylase 1 |
multiple interactions |
ISO |
[Sulindac co-treated with Putrescine] results in decreased activity of AMD1 protein |
CTD |
PMID:17474863 |
|
NCBI chr20:43,695,783...43,711,476
Ensembl chr20:43,697,237...43,711,476
|
|
G |
Amt |
aminomethyltransferase |
increases expression |
EXP |
Sulindac results in increased expression of AMT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,981,620...108,988,127
Ensembl chr 8:108,976,472...108,988,126
|
|
G |
Amz2 |
archaelysin family metallopeptidase 2 |
decreases expression |
EXP |
Sulindac results in decreased expression of AMZ2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:94,401,546...94,412,116
Ensembl chr10:94,401,579...94,412,114
|
|
G |
Angptl3 |
angiopoietin-like 3 |
decreases expression |
ISO |
Sulindac results in decreased expression of ANGPTL3 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
|
|
G |
Ankrd11 |
ankyrin repeat domain containing 11 |
increases expression |
ISO |
Sulindac results in increased expression of ANKRD11 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr19:50,940,284...51,098,962
Ensembl chr19:50,940,299...51,098,962
|
|
G |
Ankrd24 |
ankyrin repeat domain 24 |
increases expression |
EXP |
Sulindac results in increased expression of ANKRD24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:8,061,634...8,081,142
Ensembl chr 7:8,061,953...8,081,142
|
|
G |
Ankrd28 |
ankyrin repeat domain 28 |
decreases expression |
EXP |
Sulindac results in decreased expression of ANKRD28 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:6,918,487...7,050,244
Ensembl chr16:6,914,336...7,050,249
|
|
G |
Ankrd40 |
ankyrin repeat domain 40 |
increases expression |
EXP |
Sulindac results in increased expression of TMPRSS2 mRNA |
CTD |
PMID:32808185 |
|
NCBI chr10:79,282,075...79,295,322
Ensembl chr10:79,282,075...79,295,320
|
|
G |
Ap1ar |
adaptor-related protein complex 1 associated regulatory protein |
increases expression |
EXP |
Sulindac results in increased expression of AP1AR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:216,276,631...216,309,020
Ensembl chr 2:216,276,631...216,309,013
|
|
G |
Ap3d1 |
adaptor related protein complex 3 subunit delta 1 |
increases expression |
EXP |
Sulindac results in increased expression of AP3D1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:8,970,249...9,005,651
Ensembl chr 7:8,970,291...9,005,643
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
multiple interactions increases expression |
EXP |
Sulindac inhibits the reaction [Azoxymethane results in decreased expression of APC mRNA] Sulindac results in increased expression of APC protein |
CTD |
PMID:11076880 PMID:12458338 |
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apob |
apolipoprotein B |
decreases secretion |
ISO |
Sulindac results in decreased secretion of APOB protein |
CTD |
PMID:32535746 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoc3 |
apolipoprotein C3 |
decreases secretion |
ISO |
Sulindac results in decreased secretion of APOC3 protein |
CTD |
PMID:32535746 |
|
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of APP mRNA] |
CTD |
PMID:15190207 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp1 |
aquaporin 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of AQP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Arglu1 |
arginine and glutamate rich 1 |
increases expression |
ISO |
Sulindac results in increased expression of ARGLU1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr16:80,753,300...80,777,350
Ensembl chr16:80,753,315...80,777,349
|
|
G |
Arid1b |
AT-rich interaction domain 1B |
decreases expression |
EXP |
Sulindac results in decreased expression of ARID1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:45,567,991...45,923,644
Ensembl chr 1:45,563,623...45,923,493
|
|
G |
Arl1 |
ADP-ribosylation factor like GTPase 1 |
increases expression |
EXP |
Sulindac results in increased expression of ARL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:23,120,004...23,131,173
Ensembl chr 7:23,119,589...23,131,898
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
increases expression |
ISO |
Sulindac results in increased expression of ARRDC3 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression |
ISO |
Sulindac results in increased expression of ASNS mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Asnsd1 |
asparagine synthetase domain containing 1 |
increases expression |
EXP |
Sulindac results in increased expression of ASNSD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:48,126,808...48,139,073
Ensembl chr 9:48,126,808...48,139,073
|
|
G |
Ate1 |
arginyltransferase 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of ATE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:184,961,548...185,081,112
Ensembl chr 1:184,963,562...185,080,908
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
Sulindac results in increased expression of ATF3 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression |
ISO |
Sulindac results in increased expression of ATF4 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression |
ISO |
Sulindac results in increased expression of ATF6 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg3 |
autophagy related 3 |
increases expression |
EXP |
Sulindac results in increased expression of ATG3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:55,624,914...55,653,249
Ensembl chr11:55,624,917...55,653,224
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
decreases expression |
ISO |
Sulindac results in decreased expression of ATP2A1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
|
|
G |
Atp6v1a |
ATPase H+ transporting V1 subunit A |
increases expression |
EXP |
Sulindac results in increased expression of ATP6V1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:56,561,444...56,614,694
Ensembl chr11:56,560,974...56,614,694
|
|
G |
Atp6v1e1 |
ATPase H+ transporting V1 subunit E1 |
increases expression |
EXP |
Sulindac results in increased expression of ATP6V1E1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:154,022,358...154,044,486
Ensembl chr 4:154,022,358...154,044,584
|
|
G |
Auh |
AU RNA binding methylglutaconyl-CoA hydratase |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of AUH mRNA |
CTD |
PMID:20371263 |
|
NCBI chr17:12,329,522...12,424,882
Ensembl chr17:12,329,524...12,424,896
|
|
G |
Aurka |
aurora kinase A |
decreases expression |
ISO |
Sulindac results in decreased expression of AURKA mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkaip1 |
aurora kinase A interacting protein 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of AURKAIP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:166,435,177...166,436,888
Ensembl chr 5:166,417,508...166,436,882
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of B4GALT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions decreases expression |
ISO |
Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of BAD protein] Sulindac results in decreased expression of BAD protein |
CTD |
PMID:12566304 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions affects localization |
ISO |
SB 203580 inhibits the reaction [Sulindac affects the localization of BAK1 protein] |
CTD |
PMID:17136320 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases response to substance affects localization increases expression |
ISO |
SB 203580 inhibits the reaction [Sulindac affects the localization of BAX protein] BAX protein results in increased susceptibility to Sulindac Sulindac results in increased expression of BAX protein |
CTD |
PMID:11062132 PMID:17136320 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
ISO |
Sulindac results in increased expression of BBC3 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcap29 |
B-cell receptor-associated protein 29 |
increases expression |
ISO |
Sulindac results in increased expression of BCAP29 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 6:48,182,702...48,222,698
Ensembl chr 6:48,182,706...48,222,720
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
Sulindac results in decreased expression of BCL2 protein [Sulindac results in increased abundance of Reactive Oxygen Species] which results in increased cleavage of BCL2 protein [Olive Oil co-treated with Sulindac] results in decreased expression of BCL2 protein |
CTD |
PMID:10223192 PMID:15309441 PMID:15793875 PMID:17136320 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions decreases expression |
ISO |
[Sulindac co-treated with arsenic trioxide] results in increased phosphorylation of BCL2L1 protein; Acetylcysteine inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased phosphorylation of BCL2L1 protein]; MAPK8 affects the reaction [[Sulindac co-treated with arsenic trioxide] results in increased phosphorylation of BCL2L1 protein]; pyrazolanthrone inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased phosphorylation of BCL2L1 protein] Sulindac results in decreased expression of BCL2L1 protein |
CTD |
PMID:11062132 PMID:18281123 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
multiple interactions |
ISO |
[Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC2 protein |
CTD |
PMID:17136320 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
[Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC3 protein |
CTD |
PMID:17136320 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions decreases expression |
ISO |
[Sulindac co-treated with Arsenic Trioxide] results in decreased expression of BIRC5 protein; [Sulindac co-treated with Vorinostat] results in decreased expression of BIRC5 mRNA; [Sulindac co-treated with Vorinostat] results in decreased expression of BIRC5 protein; [Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC5 protein; BIRC5 protein inhibits the reaction [Sulindac results in decreased expression of STAT3 protein modified form]; BIRC5 protein inhibits the reaction [Sulindac results in decreased expression of STAT3 protein] Sulindac results in decreased expression of BIRC5 mRNA; Sulindac results in decreased expression of BIRC5 protein |
CTD |
PMID:11906190 PMID:14610217 PMID:17136320 PMID:17401459 PMID:18156316 PMID:18281123 More...
|
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Blmh |
bleomycin hydrolase |
increases expression |
EXP |
Sulindac results in increased expression of BLMH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:61,772,112...61,815,212
Ensembl chr10:61,758,478...61,815,212
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
increases expression |
EXP |
Sulindac results in increased expression of BNIP3L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Borcs7 |
BLOC-1 related complex subunit 7 |
increases expression |
EXP |
Sulindac results in increased expression of BORCS7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:245,564,347...245,578,182
Ensembl chr 1:245,564,369...245,579,343
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
ISO |
Sulindac results in decreased expression of BRCA1 mRNA |
CTD |
PMID:16273229 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brd4 |
bromodomain containing 4 |
decreases expression |
ISO |
Sulindac results in decreased expression of BRD4 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
|
|
G |
Btbd1 |
BTB domain containing 1 |
increases expression |
EXP |
Sulindac results in increased expression of BTBD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:135,734,549...135,773,067
Ensembl chr 1:135,734,589...135,771,981
|
|
G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
increases expression |
EXP |
Sulindac results in increased expression of BZW1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:59,930,672...59,944,468
Ensembl chr 9:59,930,744...59,944,430
|
|
G |
Bzw2 |
basic leucine zipper and W2 domains 2 |
decreases expression |
ISO |
Sulindac results in decreased expression of BZW2 mRNA |
CTD |
PMID:11093808 |
|
NCBI chr 6:52,828,069...52,888,599
Ensembl chr 6:52,827,661...52,888,628
|
|
G |
C17h7orf25 |
similar to human chromosome 7 open reading frame 25 |
decreases expression |
EXP |
Sulindac results in decreased expression of C17H7ORF25 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:50,543,231...50,549,880
Ensembl chr17:50,542,858...50,549,976
|
|
G |
C18h18orf32 |
similar to human chromosome 18 open reading frame 32 |
decreases expression |
EXP |
Sulindac results in decreased expression of C18H18ORF32 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:68,586,278...68,594,851
Ensembl chr18:68,586,211...68,596,787
|
|
G |
C1galt1c1 |
C1GALT1-specific chaperone 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of C1GALT1C1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:117,378,123...117,382,620
Ensembl chr X:117,375,525...117,382,787
|
|
G |
C2h1orf52 |
similar to human chromosome 1 open reading frame 52 |
increases expression |
ISO |
Sulindac results in increased expression of C1ORF52 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 2:234,853,378...234,860,045
Ensembl chr 2:234,853,410...234,860,040
|
|
G |
C4b |
complement C4B |
decreases expression |
EXP |
Sulindac results in decreased expression of C4B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
|
|
G |
Calm3 |
calmodulin 3 |
decreases expression increases expression |
ISO EXP |
Sulindac results in decreased expression of CALM3 mRNA Sulindac results in increased expression of CALM3 mRNA |
CTD |
PMID:11906190 PMID:24136188 |
|
NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207
|
|
G |
Car9 |
carbonic anhydrase 9 |
decreases expression |
ISO |
Sulindac analog results in decreased expression of CA9 mRNA |
CTD |
PMID:18924134 |
|
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity |
ISO EXP |
[Sulindac co-treated with arsenic trioxide] results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased activity of CASP3 protein]; pyrazolanthrone inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased activity of CASP3 protein] [Sulindac results in increased expression of IL24 protein] which results in increased expression of CASP3 protein Sulindac results in increased activity of CASP3 protein epigallocatechin gallate promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of CASP3 protein]]; kaempferol promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of CASP3 protein]]; Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of CASP3 protein] |
CTD |
PMID:12017300 PMID:15713900 PMID:15946692 PMID:18281123 PMID:29999212 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
[Sulindac co-treated with TNFSF10 protein] results in increased activity of CASP8 protein |
CTD |
PMID:21171083 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity increases expression |
ISO |
[Sulindac co-treated with arsenic trioxide] results in increased activity of CASP9 protein Sulindac results in increased activity of CASP9 protein [Sulindac results in increased expression of IL24 protein] which results in increased expression of CASP9 protein |
CTD |
PMID:15713900 PMID:18281123 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cast |
calpastatin |
decreases expression |
EXP |
Sulindac results in decreased expression of CAST mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
Cavin3 |
caveolae associated protein 3 |
increases expression |
ISO |
Sulindac results in increased expression of CAVIN3 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 1:159,826,549...159,828,138
Ensembl chr 1:159,826,549...159,828,161
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
Sulindac inhibits the reaction [IL1B protein results in increased expression of CCL5 mRNA]; Sulindac inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] |
CTD |
PMID:16159934 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
Sulindac results in decreased expression of CCNA2 protein |
CTD |
PMID:16488075 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Sulindac results in decreased expression of CCNB1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
ISO |
CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CCND1 protein]; Sulindac inhibits the reaction [TNF protein results in increased expression of CCND1 protein] [Sulindac co-treated with Plant Extracts] results in decreased expression of CCND1 protein |
CTD |
PMID:11504793 PMID:11593435 PMID:12351151 PMID:12584176 PMID:15020200 PMID:15489888 PMID:17292881 PMID:18291362 More...
|
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
ISO |
Sulindac results in decreased expression of CCNE1 protein |
CTD |
PMID:16488075 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccnj |
cyclin J |
decreases expression |
ISO |
Sulindac results in decreased expression of CCNJ mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 1:239,659,588...239,677,367
|
|
G |
Ccnq |
cyclin Q |
decreases expression |
EXP |
Sulindac results in decreased expression of CCNQ mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:63,646,532...63,647,695
Ensembl chr10:63,646,527...63,647,961
|
|
G |
Cct4 |
chaperonin containing TCP1 subunit 4 |
decreases expression |
EXP |
Sulindac results in decreased expression of CCT4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:96,991,853...97,004,732
Ensembl chr14:96,991,859...97,005,267
|
|
G |
Cdc37l1 |
cell division cycle 37-like 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of CDC37L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:226,705,019...226,733,994
Ensembl chr 1:226,705,003...226,761,175
|
|
G |
Cdc42ep1 |
CDC42 effector protein 1 |
increases expression |
ISO |
Sulindac results in increased expression of CDC42EP1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 7:110,395,287...110,403,203
Ensembl chr 7:110,395,332...110,403,200
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
Sulindac results in decreased expression of CDK1 mRNA |
CTD |
PMID:16273229 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions decreases activity |
ISO |
Sulindac promotes the reaction [CDKN1A protein results in decreased activity of CDK2 protein] Sulindac results in decreased activity of CDK2 protein |
CTD |
PMID:14566837 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions decreases expression |
ISO EXP |
CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CDK4 protein] [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CDK4 mRNA |
CTD |
PMID:17292881 PMID:18291362 PMID:20371263 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
Sulindac results in decreased expression of CDK6 protein |
CTD |
PMID:16488075 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions decreases activity increases activity increases expression increases response to substance |
ISO EXP |
[Sulindac co-treated with epigallocatechin gallate] results in increased expression of CDKN1A mRNA; CDKN1A protein promotes the reaction [Sulindac results in increased expression of and results in increased phosphorylation of MAPK8 protein]; CSK protein affects the reaction [Sulindac results in increased expression of CDKN1A protein]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of APP mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of CTSB mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of GBA1 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of GRN mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of IL32 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of ITGB3 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3BP mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SAA1 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SHC1 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SOD2 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of TGM2 mRNA]; Sulindac promotes the reaction [CDKN1A protein results in decreased activity of CDK2 protein] Sulindac results in decreased activity of CDKN1A protein Sulindac results in increased activity of CDKN1A protein Sulindac results in increased expression of CDKN1A mRNA; Sulindac results in increased expression of CDKN1A protein CDKN1A protein results in increased susceptibility to Sulindac [Azoxymethane co-treated with Sulindac] results in increased expression of CDKN1A protein |
CTD |
PMID:11507085 PMID:12628509 PMID:14566837 PMID:15190207 PMID:15688007 PMID:16230399 PMID:17292881 PMID:18291362 PMID:18644992 More...
|
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
EXP |
Sulindac inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] |
CTD |
PMID:12189186 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
multiple interactions |
EXP |
Sulindac inhibits the reaction [Azoxymethane results in decreased expression of CDKN2A mRNA] |
CTD |
PMID:12189186 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cep15 |
centrosomal protein 15 |
decreases expression |
EXP |
Sulindac results in decreased expression of CEP15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:12,815,159...12,835,115
Ensembl chr15:12,818,385...12,833,838
|
|
G |
Cfl2 |
cofilin 2 |
decreases expression |
EXP |
Sulindac results in decreased expression of CFL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:72,355,664...72,359,709
Ensembl chr 6:72,355,664...72,359,674
|
|
G |
Chchd3 |
coiled-coil-helix-coiled-coil-helix domain containing 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of CHCHD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:61,360,352...61,616,850
Ensembl chr 4:61,360,353...61,616,847
|
|
G |
Chchd5 |
coiled-coil-helix-coiled-coil-helix domain containing 5 |
increases expression |
EXP |
Sulindac results in increased expression of CHCHD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:116,361,845...116,372,238
Ensembl chr 3:116,361,885...116,367,169
|
|
G |
Chd8 |
chromodomain helicase DNA binding protein 8 |
decreases expression |
EXP |
Sulindac results in decreased expression of CHD8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:24,905,789...24,965,461
Ensembl chr15:24,905,789...24,951,285
|
|
G |
Chmp2a |
charged multivesicular body protein 2A |
decreases expression |
EXP |
Sulindac results in decreased expression of CHMP2A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:73,660,045...73,662,894
Ensembl chr 1:73,660,046...73,662,452
|
|
G |
Chrac1 |
chromatin accessibility complex subunit 1 |
increases expression |
EXP |
Sulindac results in increased expression of CHRAC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:105,013,047...105,016,435
Ensembl chr 7:105,013,015...105,017,136
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
ISO |
Sulindac inhibits the reaction [TNF protein results in increased activity of CHUK protein] |
CTD |
PMID:15489888 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Clpp |
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
increases expression |
EXP |
Sulindac results in increased expression of CLPP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:1,831,680...1,837,700
Ensembl chr 9:1,830,311...1,837,693
|
|
G |
Clu |
clusterin |
affects expression |
ISO |
Sulindac affects the expression of CLU protein |
CTD |
PMID:12388792 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
increases expression |
EXP |
Sulindac results in increased expression of CMTM6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:114,422,934...114,441,034
Ensembl chr 8:114,422,921...114,441,033
|
|
G |
Cngb1 |
cyclic nucleotide gated channel subunit beta 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of CNGB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:9,726,595...9,791,111
Ensembl chr19:9,726,595...9,791,173
|
|
G |
Cnnm4 |
cyclin and CBS domain divalent metal cation transport mediator 4 |
increases expression |
ISO |
Sulindac results in increased expression of CNNM4 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 9:38,711,726...38,750,942
Ensembl chr 9:38,711,710...38,750,942
|
|
G |
Cnot6 |
CCR4-NOT transcription complex, subunit 6 |
decreases expression |
EXP |
Sulindac results in decreased expression of CNOT6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:33,978,785...34,031,025
Ensembl chr10:33,980,831...34,031,025
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
increases expression |
ISO |
Sulindac results in increased expression of COL1A2 mRNA |
CTD |
PMID:18499699 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
increases expression |
ISO |
Sulindac results in increased expression of COL5A2 mRNA |
CTD |
PMID:18499699 |
|
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
increases expression |
ISO |
Sulindac results in increased expression of COL6A2 mRNA |
CTD |
PMID:18499699 |
|
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
|
|
G |
Col6a3 |
collagen type VI alpha 3 chain |
increases expression |
ISO |
Sulindac results in increased expression of COL6A3 mRNA |
CTD |
PMID:18499699 |
|
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
|
|
G |
Commd3 |
COMM domain containing 3 |
increases expression |
EXP |
Sulindac results in increased expression of COMMD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:81,327,444...81,331,191
Ensembl chr17:81,327,405...81,331,177
|
|
G |
Commd5 |
COMM domain containing 5 |
increases expression |
EXP |
Sulindac results in increased expression of COMMD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
|
|
G |
Cops7a |
COP9 signalosome subunit 7A |
increases expression |
EXP |
Sulindac results in increased expression of COPS7A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:157,766,626...157,792,632
Ensembl chr 4:157,766,588...157,773,948
|
|
G |
Cox15 |
cytochrome c oxidase assembly homolog COX15 |
increases expression |
EXP |
Sulindac results in increased expression of COX15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:242,605,588...242,622,279
Ensembl chr 1:242,605,588...242,622,261
|
|
G |
Cpne1 |
copine 1 |
decreases expression |
ISO |
Sulindac results in decreased expression of CPNE1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 3:144,587,531...144,629,911
Ensembl chr 3:144,588,995...144,598,636
|
|
G |
Cpsf3 |
cleavage and polyadenylation specific factor 3 |
increases expression |
EXP |
Sulindac results in increased expression of CPSF3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:40,836,121...40,864,129
Ensembl chr 6:40,836,097...40,864,128
|
|
G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
increases expression |
EXP |
Sulindac results in increased expression of CREB3L3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
|
|
G |
Crebzf |
CREB/ATF bZIP transcription factor |
increases expression |
EXP |
Sulindac results in increased expression of CREBZF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
decreases expression |
EXP |
Sulindac results in decreased expression of CRY2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
|
|
G |
Csf1 |
colony stimulating factor 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of CSF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Csk |
C-terminal Src kinase |
multiple interactions |
ISO EXP |
CSK protein affects the reaction [Sulindac results in increased expression of CDKN1A protein] [[Azoxymethane co-treated with Sulindac] results in increased expression of CSK protein] which results in increased phosphorylation of and results in decreased activity of SRC protein; [Azoxymethane co-treated with Sulindac] results in increased expression of CSK protein |
CTD |
PMID:18644992 |
|
NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
decreases expression increases expression |
ISO EXP |
Sulindac results in decreased expression of CSNK2A1 mRNA Sulindac results in increased expression of CSNK2A1 mRNA |
CTD |
PMID:11906190 PMID:24136188 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Csnk2a2 |
casein kinase 2 alpha 2 |
increases expression |
ISO |
Sulindac results in increased expression of CSNK2A2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr19:9,556,443...9,596,080
Ensembl chr19:9,556,260...9,596,080
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions decreases expression |
ISO EXP |
CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CCND1 protein]; CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CDK4 protein]; CTNNB1 protein affects the reaction [Sulindac results in decreased expression of MYC protein]; Sulindac results in decreased activity of [LEF1 protein binds to CTNNB1 protein] Sulindac results in decreased expression of CTNNB1 protein [Sulindac co-treated with Plant Extracts] results in decreased expression of CTNNB1 protein epigallocatechin gallate promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein]]; kaempferol promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein]]; Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein] |
CTD |
PMID:10223192 PMID:11751639 PMID:12351151 PMID:18291362 PMID:29999212 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctsb |
cathepsin B |
multiple interactions |
ISO |
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of CTSB mRNA] |
CTD |
PMID:15190207 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
multiple interactions |
ISO |
Sulindac inhibits the reaction [IFNG protein results in increased expression of CXCL9 mRNA] |
CTD |
PMID:17010317 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression increases activity decreases activity |
ISO EXP |
Sulindac results in increased expression of CYP1A1 mRNA Sulindac results in increased activity of CYP1A1 protein Sulindac results in decreased activity of CYP1A1 protein |
CTD |
PMID:16531450 PMID:17985343 PMID:33814510 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression decreases expression |
ISO EXP |
Sulindac results in increased expression of CYP1A2 mRNA Sulindac results in decreased expression of CYP1A2 mRNA |
CTD |
PMID:16531450 PMID:17985343 PMID:24136188 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression increases activity decreases activity |
ISO EXP |
Sulindac results in increased expression of CYP1B1 mRNA Sulindac results in increased activity of CYP1B1 protein Sulindac results in decreased activity of CYP1B1 protein |
CTD |
PMID:16531450 PMID:17985343 PMID:33814510 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CYP2D4 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CYP2J4 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CYP4B1 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CYP8B1 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dcn |
decorin |
decreases expression |
ISO |
Sulindac results in decreased expression of DCN mRNA |
CTD |
PMID:11507085 |
|
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
|
|
G |
Dctn5 |
dynactin subunit 5 |
decreases expression |
EXP |
Sulindac results in decreased expression of DCTN5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:176,689,176...176,705,907
Ensembl chr 1:176,689,156...176,705,906
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
[Sulindac co-treated with epigallocatechin gallate] results in increased expression of DDIT3 mRNA Sulindac results in increased expression of DDIT3 mRNA |
CTD |
PMID:12628509 PMID:24136188 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddx1 |
DEAD-box helicase 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of DDX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:35,996,469...36,027,340
Ensembl chr 6:35,996,469...36,027,365
|
|
G |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
increases expression |
EXP |
Sulindac results in increased expression of DEGS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:93,946,154...93,953,677
Ensembl chr13:93,946,157...93,953,664
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
affects localization |
ISO |
Sulindac affects the localization of DFFB protein |
CTD |
PMID:15946692 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Dhrs11 |
dehydrogenase/reductase 11 |
decreases activity |
ISO |
Sulindac results in decreased activity of DHRS11 protein |
CTD |
PMID:30926317 |
|
NCBI chr10:69,698,214...69,708,294
Ensembl chr10:69,698,214...69,708,295
|
|
G |
Dhx36 |
DEAH-box helicase 36 |
increases expression |
EXP |
Sulindac results in increased expression of DHX36 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:146,856,469...146,894,577
Ensembl chr 2:146,856,469...146,894,572
|
|
G |
Dip2c |
disco-interacting protein 2 homolog C |
increases expression |
EXP |
Sulindac results in increased expression of DIP2C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
|
|
G |
Dlg1 |
discs large MAGUK scaffold protein 1 |
increases expression |
EXP |
Sulindac results in increased expression of DLG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
increases expression |
EXP |
Sulindac results in increased expression of DNAJC10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
|
|
G |
Dnajc15 |
DnaJ heat shock protein family (Hsp40) member C15 |
increases expression |
EXP |
Sulindac results in increased expression of DNAJC15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:53,182,060...53,249,675
Ensembl chr15:53,184,855...53,249,675
|
|
G |
Dpys |
dihydropyrimidinase |
increases expression |
ISO |
Sulindac results in increased expression of DPYS mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of DYNLL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
Sulindac results in decreased expression of E2F1 protein |
CTD |
PMID:16488075 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
Eci2 |
enoyl-CoA delta isomerase 2 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ECI2 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr17:29,850,884...29,886,781
Ensembl chr17:29,870,391...29,886,781
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of BAD protein]; Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:12566304 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
decreases expression |
ISO |
Sulindac results in decreased expression of EHMT2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression |
ISO |
Sulindac results in increased expression of EIF2AK3 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
increases expression |
EXP |
Sulindac results in increased expression of EIF5B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
|
|
G |
Elapor2 |
endosome-lysosome associated apoptosis and autophagy regulator family member 2 |
increases expression |
ISO |
Sulindac results in increased expression of ELAPOR2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 4:24,613,163...24,805,729
Ensembl chr 4:24,613,163...24,805,729
|
|
G |
Eloc |
elongin C |
increases expression |
EXP |
Sulindac results in increased expression of ELOC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:2,661,527...2,677,893
Ensembl chr 5:2,661,724...2,677,890
|
|
G |
Endog |
endonuclease G |
affects localization |
ISO |
Sulindac affects the localization of ENDOG protein |
CTD |
PMID:15946692 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Ercc5 |
ERCC excision repair 5, endonuclease |
decreases expression |
ISO |
Sulindac results in decreased expression of ERCC5 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
increases expression |
ISO |
Sulindac results in increased expression of ERN1 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of ERRFI1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
|
|
G |
Ess2 |
ess-2 splicing factor homolog |
increases expression |
ISO |
Sulindac results in increased expression of ESS2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr11:83,075,893...83,085,849
Ensembl chr11:83,075,925...83,084,846
|
|
G |
Etfdh |
electron transfer flavoprotein dehydrogenase |
decreases expression |
EXP |
Sulindac results in decreased expression of ETFDH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
increases expression |
ISO |
Sulindac results in increased expression of ETS1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
|
|
G |
Exoc3 |
exocyst complex component 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of EXOC3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:29,091,298...29,122,056
Ensembl chr 1:29,091,294...29,122,045
|
|
G |
Exoc7 |
exocyst complex component 7 |
increases expression |
EXP |
Sulindac results in increased expression of EXOC7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:101,521,630...101,540,425
Ensembl chr10:101,520,927...101,540,561
|
|
G |
Exosc5 |
exosome component 5 |
decreases expression |
EXP |
Sulindac results in decreased expression of EXOSC5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:81,168,128...81,177,266
Ensembl chr 1:81,166,023...81,177,265
|
|
G |
Exosc7 |
exosome component 7 |
decreases expression |
EXP |
Sulindac results in decreased expression of EXOSC7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:122,773,607...122,798,943
Ensembl chr 8:122,773,591...122,799,270
|
|
G |
Fam219b |
family with sequence similarity 219, member B |
decreases expression |
EXP |
Sulindac results in decreased expression of FAM219B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:57,941,327...57,946,916
Ensembl chr 8:57,941,294...57,946,906
|
|
G |
Fam241b |
family with sequence similarity 241 member B |
increases expression |
EXP |
Sulindac results in increased expression of FAM241B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084
|
|
G |
Fasn |
fatty acid synthase |
increases expression |
ISO |
Sulindac results in increased expression of FASN mRNA |
CTD |
PMID:32535746 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbxl4 |
F-box and leucine-rich repeat protein 4 |
increases expression |
EXP |
Sulindac results in increased expression of FBXL4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:35,955,801...36,029,446
Ensembl chr 5:35,955,812...36,029,443
|
|
G |
Fbxo42 |
F-box protein 42 |
increases expression |
ISO |
Sulindac results in increased expression of FBXO42 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 5:153,451,162...153,509,564
Ensembl chr 5:153,451,153...153,506,342
|
|
G |
Fbxo6 |
F-box protein 6 |
decreases expression |
EXP |
Sulindac results in decreased expression of FBXO6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:158,576,729...158,582,520
Ensembl chr 5:158,576,759...158,582,525
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
increases expression |
ISO |
Sulindac results in increased expression of FHL2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
decreases expression |
EXP |
Sulindac results in decreased expression of FKBP1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Fli1 |
Fli-1 proto-oncogene, ETS transcription factor |
decreases expression |
EXP |
Sulindac results in decreased expression of FLI1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:30,831,422...30,950,468
Ensembl chr 8:30,832,753...30,950,433
|
|
G |
Flnb |
filamin B |
increases expression |
EXP |
Sulindac results in increased expression of FLNB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
affects metabolic processing multiple interactions increases metabolic processing |
ISO |
FMO3 gene polymorphism affects the metabolism of Sulindac FMO3 gene polymorphism results in decreased metabolism of and results in increased susceptibility to Sulindac FMO3 protein results in increased metabolism of Sulindac |
CTD |
PMID:15623613 PMID:17050781 |
|
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
ISO |
Sulindac results in decreased expression of FOS protein |
CTD |
PMID:15020200 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
Sulindac results in increased expression of FTH1 mRNA |
CTD |
PMID:11093808 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Ftl1 |
ferritin light chain 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of FTL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
|
|
G |
Fxn |
frataxin |
increases expression |
EXP |
Sulindac results in increased expression of FXN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
Sulindac results in increased expression of GADD45A mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gal |
galanin and GMAP prepropeptide |
affects expression |
ISO |
Sulindac affects the expression of GAL protein |
CTD |
PMID:12388792 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Galk1 |
galactokinase 1 |
increases expression |
EXP |
Sulindac results in increased expression of GALK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:101,243,146...101,247,323
Ensembl chr10:101,235,994...101,247,337
|
|
G |
Gap43 |
growth associated protein 43 |
affects expression |
ISO |
Sulindac affects the expression of GAP43 protein |
CTD |
PMID:12388792 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gatad1 |
GATA zinc finger domain containing 1 |
increases expression |
EXP |
Sulindac results in increased expression of GATAD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:30,507,530...30,519,107
Ensembl chr 4:30,507,538...30,519,107
|
|
G |
Gatad2a |
GATA zinc finger domain containing 2A |
increases expression |
EXP |
Sulindac results in increased expression of GATAD2A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:19,429,578...19,520,320
Ensembl chr16:19,429,578...19,519,587
|
|
G |
Gatd3a |
glutamine amidotransferase class 1 domain containing 3A |
decreases expression |
ISO |
Sulindac results in decreased expression of GATD3 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
|
|
G |
Gba1 |
glucosylceramidase beta 1 |
multiple interactions |
ISO |
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of GBA1 mRNA] |
CTD |
PMID:15190207 |
|
NCBI chr 2:174,609,437...174,615,457
Ensembl chr 2:174,609,403...174,618,263
|
|
G |
Gcdh |
glutaryl-CoA dehydrogenase |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of GCDH mRNA |
CTD |
PMID:20371263 |
|
NCBI chr19:23,263,215...23,269,689
Ensembl chr19:23,263,264...23,269,681
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions affects expression increases expression |
ISO |
Acetylcysteine inhibits the reaction [Sulindac results in increased expression of GCLC protein] Sulindac affects the expression of GCLC mRNA |
CTD |
PMID:11820781 PMID:15946948 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1 |
increases expression |
ISO |
Sulindac results in increased expression of GCNT1 mRNA |
CTD |
PMID:11093808 |
|
NCBI chr 1:214,718,344...214,755,735
Ensembl chr 1:214,718,293...214,758,776
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
Sulindac results in increased expression of GDF15 mRNA; Sulindac results in increased expression of GDF15 protein |
CTD |
PMID:11906190 PMID:11984525 PMID:15180942 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Ghitm |
growth hormone inducible transmembrane protein |
increases expression |
EXP |
Sulindac results in increased expression of GHITM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:12,885,551...12,897,887
Ensembl chr16:12,885,553...12,897,879
|
|
G |
Ghr |
growth hormone receptor |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of GHR mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Glo1 |
glyoxalase 1 |
decreases activity |
ISO |
Sulindac results in decreased activity of GLO1 protein |
CTD |
PMID:17243824 |
|
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
|
|
G |
Gnas |
GNAS complex locus |
increases expression |
EXP |
Sulindac results in increased expression of GNAS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gnl3l |
G protein nucleolar 3 like |
decreases expression |
EXP |
Sulindac results in decreased expression of GNL3L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:19,961,277...19,994,454
Ensembl chr X:19,958,603...19,994,508
|
|
G |
Gnmt |
glycine N-methyltransferase |
decreases expression |
EXP |
Sulindac results in decreased expression of GNMT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of GPX3 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Grb10 |
growth factor receptor bound protein 10 |
increases expression |
ISO |
Sulindac results in increased expression of GRB10 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr14:86,495,051...86,602,800
Ensembl chr14:86,495,054...86,602,806
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
increases expression |
EXP |
Sulindac results in increased expression of GRB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
affects expression |
EXP |
Sulindac affects the expression of GRIN1 protein |
CTD |
PMID:15123337 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
affects expression |
EXP |
Sulindac affects the expression of GRIN2B protein |
CTD |
PMID:15123337 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Grk6 |
G protein-coupled receptor kinase 6 |
decreases expression |
EXP |
Sulindac results in decreased expression of GRK6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:9,177,018...9,192,813
Ensembl chr17:9,177,019...9,192,644
|
|
G |
Grn |
granulin precursor |
multiple interactions |
ISO |
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of GRN mRNA] |
CTD |
PMID:15190207 |
|
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases phosphorylation |
ISO |
Sulindac results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:11593435 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of GSTM2 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression |
EXP |
Sulindac results in increased expression of GSTT1 protein |
CTD |
PMID:9729437 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gtf2b |
general transcription factor IIB |
increases expression decreases expression |
ISO EXP |
Sulindac results in increased expression of GTF2B mRNA Sulindac results in decreased expression of GTF2B mRNA |
CTD |
PMID:11906190 PMID:24136188 |
|
NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
ISO |
[Arsenic Trioxide co-treated with Sulindac] results in increased phosphorylation of H2AX protein |
CTD |
PMID:18636201 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
H2az1 |
H2A.Z variant histone 1 |
increases expression |
EXP |
Sulindac results in increased expression of H2AZ1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:226,355,668...226,357,984
Ensembl chr 2:226,355,708...226,358,485
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
decreases expression |
EXP |
Sulindac results in decreased expression of HADHB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Helz2 |
helicase with zinc finger 2 |
decreases expression |
EXP |
Sulindac results in decreased expression of HELZ2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159
|
|
G |
Herpud1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
increases expression |
ISO |
Sulindac results in increased expression of HERPUD1 mRNA |
CTD |
PMID:11093808 |
|
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions decreases expression |
ISO |
[AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein]] which affects the susceptibility to Oxygen; AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein] Sulindac analog results in decreased expression of HIF1A mRNA; Sulindac analog results in decreased expression of HIF1A protein |
CTD |
PMID:18924134 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Higd1a |
HIG1 hypoxia inducible domain family, member 1A |
increases expression |
EXP |
Sulindac results in increased expression of HIGD1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:121,514,152...121,523,382
Ensembl chr 8:121,514,156...121,523,443
|
|
G |
Hlcs |
holocarboxylase synthetase |
decreases expression |
ISO |
Sulindac results in decreased expression of HLCS mRNA |
CTD |
PMID:11906190 |
|
NCBI chr11:33,455,806...33,635,197
Ensembl chr11:33,455,809...33,624,222
|
|
G |
Hmgb3 |
high mobility group box 3 |
increases expression |
EXP |
Sulindac results in increased expression of HMGB3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:149,296,303...149,301,290
Ensembl chr X:149,296,375...149,301,292
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
decreases expression |
ISO |
Sulindac results in decreased expression of HMMR mRNA |
CTD |
PMID:11906190 |
|
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sulindac promotes the reaction [arsenic trioxide results in increased expression of HMOX1 protein]]; pyrazolanthrone inhibits the reaction [Sulindac promotes the reaction [arsenic trioxide results in increased expression of HMOX1 protein]]; SB 203580 inhibits the reaction [Sulindac promotes the reaction [arsenic trioxide results in increased expression of HMOX1 protein]]; Sulindac promotes the reaction [arsenic trioxide results in increased expression of HMOX1 protein] Sulindac results in decreased expression of HMOX1 protein |
CTD |
PMID:18636201 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of HNF4A mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of HSD17B4 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
increases activity |
ISO |
Sulindac results in increased activity of HSF1 protein |
CTD |
PMID:10328874 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
increases expression |
EXP |
Sulindac results in increased expression of HSPA9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
ISO |
Sulindac results in decreased expression of ICAM1 protein |
CTD |
PMID:18059344 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifi27 |
interferon, alpha-inducible protein 27 |
decreases expression |
EXP |
Sulindac results in decreased expression of IFI27 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of IFITM3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifnar1 |
interferon alpha and beta receptor subunit 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of IFNAR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:30,725,774...30,752,227
Ensembl chr11:30,725,790...30,749,979
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Sulindac inhibits the reaction [IFNG protein results in increased expression of CXCL9 mRNA] |
CTD |
PMID:17010317 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Iftap |
intraflagellar transport associated protein |
increases expression |
EXP |
Sulindac results in increased expression of IFTAP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:87,812,068...87,906,517
Ensembl chr 3:87,817,408...87,906,547
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
decreases activity |
ISO |
Sulindac results in decreased activity of IKBKB protein |
CTD |
PMID:19526344 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il11ra1 |
interleukin 11 receptor subunit alpha 1 |
increases expression |
EXP |
Sulindac results in increased expression of IL11RA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:56,931,824...56,941,408
Ensembl chr 5:56,935,516...56,941,408
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of IL1A mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression increases expression |
ISO EXP |
[Sulindac co-treated with epigallocatechin gallate] results in decreased expression of IL1B mRNA; Sulindac inhibits the reaction [IL1B protein results in increased abundance of Hyaluronic Acid]; Sulindac inhibits the reaction [IL1B protein results in increased expression of CCL5 mRNA] Sulindac results in decreased expression of IL1B mRNA Sulindac results in decreased expression of IL1B protein Sulindac results in increased expression of IL1B |
CTD |
PMID:10328874 PMID:11318944 PMID:12628509 PMID:15123337 PMID:16159934 PMID:24136188 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il24 |
interleukin 24 |
multiple interactions increases expression |
ISO |
Sulindac promotes the reaction [IL24 protein results in increased phosphorylation of MAPK8 protein] [Sulindac results in increased expression of IL24 protein] which results in increased expression of CASP3 protein; [Sulindac results in increased expression of IL24 protein] which results in increased expression of CASP9 protein; Sulindac results in increased expression of IL24 protein |
CTD |
PMID:15713900 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of IL6 mRNA Sulindac results in increased expression of IL6 |
CTD |
PMID:20371263 PMID:24136188 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ilk |
integrin-linked kinase |
decreases activity |
ISO |
Sulindac results in decreased activity of ILK protein |
CTD |
PMID:11593435 |
|
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
|
|
G |
Inpp5e |
inositol polyphosphate-5-phosphatase E |
increases expression |
ISO |
Sulindac results in increased expression of INPP5E mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 3:9,216,776...9,229,539
Ensembl chr 3:9,216,776...9,229,450
|
|
G |
Ipmk |
inositol polyphosphate multikinase |
decreases expression |
EXP |
Sulindac results in decreased expression of IPMK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:17,216,988...17,251,675
Ensembl chr20:17,218,037...17,251,705
|
|
G |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of IRAK2 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 4:146,786,004...146,842,615
Ensembl chr 4:146,786,100...146,842,602
|
|
G |
Irf7 |
interferon regulatory factor 7 |
decreases expression |
EXP |
Sulindac results in decreased expression of IRF7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Isca1 |
iron-sulfur cluster assembly 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of ISCA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:4,905,291...4,917,955
Ensembl chr17:4,905,287...4,917,955
|
|
G |
Itga2 |
integrin subunit alpha 2 |
increases expression |
ISO |
Sulindac results in increased expression of ITGA2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
|
|
G |
Itgb3 |
integrin subunit beta 3 |
multiple interactions |
ISO |
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of ITGB3 mRNA] |
CTD |
PMID:15190207 |
|
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Itgb4 |
integrin subunit beta 4 |
multiple interactions |
ISO |
[Sulindac co-treated with epigallocatechin gallate] results in decreased expression of ITGB4 mRNA |
CTD |
PMID:12628509 |
|
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Jkamp |
JNK1/MAPK8-associated membrane protein |
decreases expression |
EXP |
Sulindac results in decreased expression of JKAMP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:90,648,043...90,661,985
Ensembl chr 6:90,648,160...90,662,501
|
|
G |
Josd1 |
Josephin domain containing 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of JOSD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:111,230,318...111,244,241
Ensembl chr 7:111,230,318...111,244,652
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression multiple interactions |
ISO |
Sulindac results in decreased expression of JUN protein [Sulindac co-treated with Plant Extracts] results in decreased expression of JUN protein |
CTD |
PMID:12351151 PMID:12584176 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Sulindac results in increased expression of JUND mRNA |
CTD |
PMID:11906190 |
|
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Kcnh3 |
potassium voltage-gated channel subfamily H member 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of KCNH3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:130,365,593...130,383,859
Ensembl chr 7:130,366,011...130,383,855
|
|
G |
Kctd5 |
potassium channel tetramerization domain containing 5 |
increases expression |
EXP |
Sulindac results in increased expression of KCTD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,079,216...13,105,197
Ensembl chr10:13,079,214...13,105,209
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of KEAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Khsrp |
KH-type splicing regulatory protein |
increases expression |
EXP |
Sulindac results in increased expression of KHSRP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:1,862,555...1,872,403
Ensembl chr 9:1,862,899...1,872,451
|
|
G |
Kif14 |
kinesin family member 14 |
increases expression |
ISO |
Sulindac results in increased expression of KIF14 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr13:47,926,975...47,990,598
Ensembl chr13:47,927,044...47,989,164
|
|
G |
Klf5 |
KLF transcription factor 5 |
increases expression |
ISO |
Sulindac results in increased expression of KLF5 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
affects response to substance |
ISO |
KRAS protein affects the susceptibility to Sulindac |
CTD |
PMID:11751493 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Lad1 |
ladinin 1 |
increases expression |
ISO |
Sulindac results in increased expression of LAD1 mRNA |
CTD |
PMID:11507085 |
|
NCBI chr13:47,249,605...47,263,967
Ensembl chr13:47,249,605...47,263,967
|
|
G |
Lamtor4 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 |
decreases expression |
EXP |
Sulindac results in decreased expression of LAMTOR4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:17,258,656...17,262,478
Ensembl chr12:17,258,623...17,262,480
|
|
G |
Larp1b |
La ribonucleoprotein 1B |
decreases expression |
EXP |
Sulindac results in decreased expression of LARP1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
|
|
G |
Larp4 |
La ribonucleoprotein 4 |
increases expression |
ISO |
Sulindac results in increased expression of LARP4 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 7:131,104,470...131,152,692
Ensembl chr 7:131,101,564...131,150,811
|
|
G |
Lbp |
lipopolysaccharide binding protein |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of LBP mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Ldb1 |
LIM domain binding 1 |
increases expression |
ISO |
Sulindac results in increased expression of LDB1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 1:244,864,168...244,890,007
Ensembl chr 1:244,877,173...244,890,013
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
multiple interactions |
ISO |
Sulindac results in decreased activity of [LEF1 protein binds to CTNNB1 protein] |
CTD |
PMID:11751639 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
increases expression |
ISO |
Sulindac results in increased expression of LFNG mRNA |
CTD |
PMID:11906190 |
|
NCBI chr12:14,030,551...14,038,996
Ensembl chr12:14,018,333...14,039,008
|
|
G |
Lgals3 |
galectin 3 |
multiple interactions |
ISO |
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3 mRNA] |
CTD |
PMID:15190207 |
|
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Lgals3bp |
galectin 3 binding protein |
multiple interactions |
ISO |
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3BP mRNA] |
CTD |
PMID:15190207 |
|
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
|
|
G |
Lipe |
lipase E, hormone sensitive type |
decreases expression |
EXP |
Sulindac results in decreased expression of LIPE mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310
|
|
G |
Litaf |
lipopolysaccharide-induced TNF factor |
increases expression |
EXP |
Sulindac results in increased expression of LITAF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
|
|
G |
Lmf2 |
lipase maturation factor 2 |
decreases expression |
EXP |
Sulindac results in decreased expression of LMF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:120,418,343...120,422,825
Ensembl chr 7:120,418,345...120,422,823
|
|
G |
Lonp1 |
lon peptidase 1, mitochondrial |
decreases expression |
EXP |
Sulindac results in decreased expression of LONP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
|
|
G |
Lox |
lysyl oxidase |
decreases expression |
ISO |
Sulindac analog results in decreased expression of LOX mRNA |
CTD |
PMID:18924134 |
|
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Lrpprc |
leucine-rich pentatricopeptide repeat containing |
decreases expression |
EXP |
Sulindac results in decreased expression of LRPPRC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:9,859,816...9,942,294
Ensembl chr 6:9,859,867...9,942,293
|
|
G |
Lsm10 |
LSM10, U7 small nuclear RNA associated |
increases expression |
EXP |
Sulindac results in increased expression of LSM10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:138,365,983...138,375,856
Ensembl chr 5:138,373,119...138,377,505
|
|
G |
Lsm12 |
LSM12 homolog |
increases expression |
EXP |
Sulindac results in increased expression of LSM12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:87,118,334...87,140,395
Ensembl chr10:87,118,416...87,140,396
|
|
G |
Lsm6 |
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated |
increases expression |
EXP |
Sulindac results in increased expression of LSM6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:29,098,254...29,112,858
Ensembl chr13:42,114,032...42,116,484 Ensembl chr19:42,114,032...42,116,484
|
|
G |
Macroh2a1 |
macroH2A.1 histone |
decreases expression |
EXP |
Sulindac results in decreased expression of MACROH2A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:8,479,331...8,542,071
Ensembl chr17:8,479,372...8,542,072
|
|
G |
Maoa |
monoamine oxidase A |
decreases expression |
EXP |
Sulindac results in decreased expression of MAOA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Maob |
monoamine oxidase B |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of MAOB mRNA |
CTD |
PMID:20371263 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of MAP3K8 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
|
|
G |
Map4k3 |
mitogen-activated protein kinase kinase kinase kinase 3 |
increases expression |
ISO |
Sulindac results in increased expression of MAP4K3 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 6:14,276,623...14,446,321
Ensembl chr 6:14,277,121...14,446,334
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO EXP |
[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK1 protein; Arsenic Trioxide promotes the reaction [Sulindac results in increased phosphorylation of MAPK1 protein]; Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; Sulindac promotes the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein] [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of MAPK1 mRNA |
CTD |
PMID:12566304 PMID:18281123 PMID:18636201 PMID:20371263 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK3 protein; Arsenic Trioxide promotes the reaction [Sulindac results in increased phosphorylation of MAPK3 protein]; Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; Sulindac promotes the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:12566304 PMID:18281123 PMID:18636201 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions increases expression increases phosphorylation |
ISO |
CDKN1A protein promotes the reaction [Sulindac results in increased expression of and results in increased phosphorylation of MAPK8 protein]; MAPK8 affects the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of BCL2L1 protein]; Sulindac promotes the reaction [IL24 protein results in increased phosphorylation of MAPK8 protein]; Sulindac results in increased expression of and results in increased phosphorylation of MAPK8 protein; Sulindac results in increased phosphorylation of and results in increased activity of MAPK8 protein Sulindac results in increased expression of MAPK8 mRNA Sulindac results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:15713900 PMID:17292881 PMID:18281123 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mark3 |
microtubule affinity regulating kinase 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of MARK3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:130,626,612...130,716,245
Ensembl chr 6:130,627,482...130,716,647
|
|
G |
Mbd2 |
methyl-CpG binding domain protein 2 |
decreases expression |
EXP |
Sulindac results in decreased expression of MBD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
|
|
G |
Mbd3 |
methyl-CpG binding domain protein 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of MBD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:9,312,961...9,320,166
Ensembl chr 7:9,313,098...9,320,165
|
|
G |
Me1 |
malic enzyme 1 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ME1 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Med10 |
mediator complex subunit 10 |
increases expression |
EXP |
Sulindac results in increased expression of MED10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:33,470,064...33,481,698
Ensembl chr 1:33,470,066...33,475,767
|
|
G |
Med15 |
mediator complex subunit 15 |
increases expression |
ISO |
Sulindac results in increased expression of MED15 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr11:83,280,722...83,356,006
Ensembl chr11:83,280,762...83,355,362
|
|
G |
Mesd |
mesoderm development LRP chaperone |
decreases expression |
EXP |
Sulindac results in decreased expression of MESD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:137,866,707...137,879,999
Ensembl chr 1:137,874,242...137,879,999
|
|
G |
Mettl23 |
methyltransferase 23, arginine |
increases expression |
EXP |
Sulindac results in increased expression of METTL23 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:102,047,090...102,053,379
Ensembl chr10:102,047,314...102,051,977
|
|
G |
Mfap3 |
microfibril associated protein 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of MFAP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:41,696,788...41,711,490
Ensembl chr10:41,696,771...41,710,406
|
|
G |
Mff |
mitochondrial fission factor |
decreases expression |
EXP |
Sulindac results in decreased expression of MFF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:84,007,798...84,036,039
Ensembl chr 9:84,007,798...84,036,039
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of MGST2 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
|
|
G |
Mgst3 |
microsomal glutathione S-transferase 3 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of MGST3 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr13:79,526,541...79,547,479
Ensembl chr13:79,526,541...79,547,411
|
|
G |
Miip |
migration and invasion inhibitory protein |
increases expression |
ISO |
Sulindac results in increased expression of MIIP mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 5:158,292,510...158,299,533
Ensembl chr 5:158,292,511...158,299,694
|
|
G |
Mllt6 |
MLLT6, PHD finger containing |
decreases expression |
EXP |
Sulindac results in decreased expression of MLLT6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:82,657,258...82,678,899
Ensembl chr10:82,656,872...82,676,073
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
decreases expression |
EXP |
Sulindac results in decreased expression of MMP14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
decreases expression |
ISO |
Sulindac results in decreased expression of MMP7 mRNA; Sulindac results in decreased expression of MMP7 protein |
CTD |
PMID:18499699 |
|
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mogs |
mannosyl-oligosaccharide glucosidase |
decreases expression |
EXP |
Sulindac results in decreased expression of MOGS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:115,621,623...115,625,026
Ensembl chr 4:115,621,623...115,625,032
|
|
G |
Mrpl1 |
mitochondrial ribosomal protein L1 |
decreases expression |
EXP |
Sulindac results in decreased expression of MRPL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:13,300,522...13,359,654
Ensembl chr14:13,300,522...13,359,721
|
|
G |
mrpl11 |
mitochondrial ribosomal protein L11 |
decreases expression |
EXP |
Sulindac results in decreased expression of MRPL11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:202,264,419...202,267,288
Ensembl chr 1:202,264,471...202,267,756
|
|
G |
Mrpl13 |
mitochondrial ribosomal protein L13 |
increases expression |
EXP |
Sulindac results in increased expression of MRPL13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:86,951,541...86,973,147
Ensembl chr 7:86,951,541...86,973,577
|
|
G |
Mrpl17 |
mitochondrial ribosomal protein L17 |
decreases expression |
EXP |
Sulindac results in decreased expression of MRPL17 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:160,162,181...160,163,870
Ensembl chr 1:160,158,807...160,163,815
|
|
G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
decreases expression |
EXP |
Sulindac results in decreased expression of MRPL20 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:166,408,962...166,413,492
Ensembl chr 5:166,408,962...166,413,492
|
|
G |
Mrpl22 |
mitochondrial ribosomal protein L22 |
increases expression |
EXP |
Sulindac results in increased expression of MRPL22 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:42,345,446...42,355,779
Ensembl chr10:42,342,776...42,355,779
|
|
G |
Mrpl23 |
mitochondrial ribosomal protein L23 |
decreases expression |
EXP |
Sulindac results in decreased expression of MRPL23 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:197,687,452...197,695,222
Ensembl chr 1:197,687,347...197,695,222
|
|
G |
Mrpl32 |
mitochondrial ribosomal protein L32 |
increases expression |
EXP |
Sulindac results in increased expression of MRPL32 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:50,565,133...50,568,000
Ensembl chr17:50,565,055...50,568,010
|
|
G |
Mrpl37 |
mitochondrial ribosomal protein L37 |
decreases expression |
EXP |
Sulindac results in decreased expression of MRPL37 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:121,827,892...121,846,187
Ensembl chr 5:121,829,111...121,846,176
|
|
G |
Mrpl53 |
mitochondrial ribosomal protein L53 |
increases expression |
EXP |
Sulindac results in increased expression of MRPL53 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:115,615,329...115,616,219
|
|
G |
Mrpl54 |
mitochondrial ribosomal protein L54 |
increases expression |
EXP |
Sulindac results in increased expression of MRPL54 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:8,452,801...8,455,321
Ensembl chr 7:8,452,716...8,455,321
|
|
G |
Mrpl58 |
mitochondrial ribosomal protein L58 |
decreases expression |
EXP |
Sulindac results in decreased expression of MRPL58 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:100,646,374...100,652,871
Ensembl chr10:100,646,216...100,652,871
|
|
G |
Mrps14 |
mitochondrial ribosomal protein S14 |
decreases expression |
EXP |
Sulindac results in decreased expression of MRPS14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:72,429,168...72,434,915
Ensembl chr13:72,408,558...72,434,915
|
|
G |
Mrps24 |
mitochondrial ribosomal protein S24 |
decreases expression |
EXP |
Sulindac results in decreased expression of MRPS24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:80,584,671...80,588,801
Ensembl chr14:80,584,673...80,588,871
|
|
G |
Mrps31 |
mitochondrial ribosomal protein S31 |
decreases expression |
EXP |
Sulindac results in decreased expression of MRPS31 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:69,601,349...69,621,609
Ensembl chr16:69,601,349...69,630,654
|
|
G |
Mrps33 |
mitochondrial ribosomal protein S33 |
increases expression |
EXP |
Sulindac results in increased expression of MRPS33 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:68,596,729...68,605,547
Ensembl chr 4:68,596,729...68,605,428
|
|
G |
Mrps7 |
mitochondrial ribosomal protein S7 |
decreases expression |
EXP |
Sulindac results in decreased expression of MRPS7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:100,843,691...100,846,838
Ensembl chr10:100,843,356...100,847,129
|
|
G |
Mrps9 |
mitochondrial ribosomal protein S9 |
increases expression |
EXP |
Sulindac results in increased expression of MRPS9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:45,113,554...45,172,375
Ensembl chr 9:45,113,554...45,172,375
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
increases expression |
ISO |
Sulindac results in increased expression of MTHFD2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Mtpn |
myotrophin |
increases expression |
EXP |
Sulindac results in increased expression of MTPN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:64,159,273...64,186,686
Ensembl chr 4:64,157,641...64,186,724
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
increases expression |
ISO |
Sulindac results in increased expression of MTTP mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Mug1 |
murinoglobulin 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of MUG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:155,076,270...155,130,051
Ensembl chr 4:155,076,312...155,130,051
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions increases expression decreases expression |
ISO EXP |
CTNNB1 protein affects the reaction [Sulindac results in decreased expression of MYC protein] Sulindac results in increased expression of MYC mRNA Sulindac inhibits the reaction [Azoxymethane results in increased expression of MYC mRNA]; Sulindac inhibits the reaction [Azoxymethane results in increased expression of MYC protein] |
CTD |
PMID:12189186 PMID:12414619 PMID:17292881 PMID:18291362 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Mzf1 |
myeloid zinc finger 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of MZF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:73,670,522...73,682,885
Ensembl chr 1:73,670,541...73,681,635
|
|
G |
Naa35 |
N(alpha)-acetyltransferase 35, NatC auxiliary subunit |
decreases expression |
EXP |
Sulindac results in decreased expression of NAA35 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:5,034,360...5,086,456
Ensembl chr17:5,034,356...5,086,386
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
decreases expression |
EXP |
Sulindac results in decreased expression of NAMPT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
decreases expression |
ISO |
Sulindac results in decreased expression of NAP1L1 mRNA |
CTD |
PMID:11507085 |
|
NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593
|
|
G |
Nat1 |
N-acetyltransferase 1 |
decreases expression |
ISO |
Sulindac results in decreased expression of NAT1 mRNA |
CTD |
PMID:11828994 |
|
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
increases expression decreases expression |
ISO EXP |
Sulindac results in increased expression of NDRG1 mRNA Sulindac results in decreased expression of NDRG1 mRNA |
CTD |
PMID:16273229 PMID:24136188 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Ndst2 |
N-deacetylase and N-sulfotransferase 2 |
decreases expression |
ISO |
Sulindac results in decreased expression of NDST2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr15:3,563,515...3,573,801
Ensembl chr15:3,563,358...3,573,801
|
|
G |
Ndufa5 |
NADH:ubiquinone oxidoreductase subunit A5 |
increases expression |
EXP |
Sulindac results in increased expression of NDUFA5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:52,997,327...53,005,685
Ensembl chr 4:52,995,546...53,005,598
|
|
G |
Ndufv3 |
NADH:ubiquinone oxidoreductase subunit V3 |
increases expression |
EXP |
Sulindac results in increased expression of NDUFV3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:9,612,462...9,621,622
Ensembl chr20:9,612,431...9,623,074 Ensembl chr13:9,612,431...9,623,074
|
|
G |
Nek7 |
NIMA-related kinase 7 |
decreases expression |
EXP |
Sulindac results in decreased expression of NEK7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:50,022,212...50,149,374
Ensembl chr13:50,022,218...50,149,296
|
|
G |
Neu1 |
neuraminidase 1 |
increases expression |
ISO |
Sulindac results in increased expression of NEU1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr20:3,897,480...3,901,745
Ensembl chr20:3,897,480...3,901,745
|
|
G |
Nfe2l1 |
NFE2 like bZIP transcription factor 1 |
increases expression |
ISO EXP |
Sulindac results in increased expression of NFE2L1 mRNA |
CTD |
PMID:11906190 PMID:24136188 |
|
NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
|
|
G |
Nfib |
nuclear factor I/B |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of NFIB mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 5:96,759,208...96,974,001
Ensembl chr 5:96,764,653...96,975,479
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
increases expression |
ISO |
Sulindac results in increased expression of NFIL3 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions decreases activity |
ISO |
Acetylcysteine inhibits the reaction [Sulindac analog results in decreased activity of NFKB1 protein]; Sulindac inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; Sulindac inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] |
CTD |
PMID:15489888 PMID:18922898 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions decreases phosphorylation |
ISO EXP |
[[Sulindac co-treated with arsenic trioxide] results in decreased phosphorylation of and results in decreased degradation of NFKBIA protein] which affects the localization of RELA protein; [Sulindac co-treated with arsenic trioxide] results in decreased phosphorylation of and results in decreased degradation of NFKBIA protein; Sulindac inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; Sulindac results in increased degradation of and results in decreased expression of NFKBIA protein Sulindac results in decreased phosphorylation of NFKBIA protein [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of NFKBIA mRNA |
CTD |
PMID:11591705 PMID:15489888 PMID:18059344 PMID:18575716 PMID:20371263 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfu1 |
NFU1 iron-sulfur cluster scaffold |
decreases expression |
EXP |
Sulindac results in decreased expression of NFU1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:119,458,981...119,480,162
Ensembl chr 4:119,459,061...119,480,373
|
|
G |
Npc1 |
NPC intracellular cholesterol transporter 1 |
increases expression |
ISO |
Sulindac results in increased expression of NPC1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
|
|
G |
Nphp1 |
nephrocystin 1 |
increases expression |
EXP |
Sulindac results in increased expression of NPHP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:114,960,650...115,016,234
Ensembl chr 3:114,960,650...115,016,234
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity increases expression |
ISO |
Sulindac results in increased activity of NQO1 protein Sulindac results in increased expression of NQO1 mRNA |
CTD |
PMID:11093808 PMID:17985343 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nsmf |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
decreases expression |
EXP |
Sulindac results in decreased expression of NSMF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:7,861,846...7,870,615
Ensembl chr 3:7,861,872...7,870,614
|
|
G |
Nudt16l1 |
nudix hydrolase 16 like 1 |
increases expression |
EXP |
Sulindac results in increased expression of NUDT16L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:10,636,174...10,638,090
Ensembl chr10:10,636,174...10,688,370
|
|
G |
Numb |
NUMB, endocytic adaptor protein |
increases expression |
EXP |
Sulindac results in increased expression of NUMB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:103,431,400...103,553,422
Ensembl chr 6:103,431,400...103,553,354
|
|
G |
Nup37 |
nucleoporin 37 |
increases expression |
EXP |
Sulindac results in increased expression of NUP37 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:22,556,544...22,609,622
Ensembl chr 7:22,573,764...22,609,616
|
|
G |
Nupr2 |
nuclear protein 2, transcriptional regulator |
increases expression |
EXP |
Sulindac results in increased expression of NUPR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:26,800,123...26,803,228
Ensembl chr12:26,799,800...26,803,304
|
|
G |
Orc4 |
origin recognition complex, subunit 4 |
decreases expression |
ISO |
Sulindac results in decreased expression of ORC4 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 3:33,290,844...33,334,022
Ensembl chr 3:33,294,355...33,333,824
|
|
G |
Osbpl9 |
oxysterol binding protein-like 9 |
decreases expression |
EXP |
Sulindac results in decreased expression of OSBPL9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:123,819,106...123,962,213
Ensembl chr 5:123,819,104...123,962,196
|
|
G |
Ostf1 |
osteoclast stimulating factor 1 |
increases expression |
ISO |
Sulindac results in increased expression of OSTF1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 1:216,002,037...216,049,226
Ensembl chr 1:216,002,044...216,049,221
|
|
G |
Ostm1 |
osteoclastogenesis associated transmembrane protein 1 |
increases expression |
EXP |
Sulindac results in increased expression of OSTM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:46,071,657...46,187,049
Ensembl chr20:46,153,075...46,187,023
|
|
G |
Otud1 |
OTU deubiquitinase 1 |
increases expression |
ISO |
Sulindac results in increased expression of OTUD1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr17:82,259,920...82,262,770
Ensembl chr17:82,259,840...82,262,995
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
decreases expression |
ISO |
Sulindac results in decreased expression of P4HB mRNA |
CTD |
PMID:32535746 |
|
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
|
|
G |
Pacsin3 |
protein kinase C and casein kinase substrate in neurons 3 |
increases expression |
EXP |
Sulindac results in increased expression of PACSIN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:77,227,187...77,235,820
Ensembl chr 3:77,222,710...77,235,811
|
|
G |
Pak6 |
p21 (RAC1) activated kinase 6 |
decreases expression |
EXP |
Sulindac results in decreased expression of PAK6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:105,638,248...105,674,399
Ensembl chr 3:105,638,653...105,672,975
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases activity |
ISO |
[Sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein]; pyrazolanthrone inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein]; Sulindac promotes the reaction [Deferoxamine results in increased cleavage of PARP1 protein] Sulindac results in increased activity of PARP1 protein |
CTD |
PMID:15713900 PMID:18281123 PMID:21882223 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
decreases expression |
EXP |
Sulindac results in decreased expression of PARP14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
|
|
G |
Pbrm1 |
polybromo 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of PBRM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:6,213,507...6,312,895
Ensembl chr16:6,213,300...6,311,780
|
|
G |
Pcbp1 |
poly(rC) binding protein 1 |
increases expression |
EXP |
Sulindac results in increased expression of PCBP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:118,972,698...118,974,705
Ensembl chr 4:118,972,661...118,976,500
|
|
G |
Pcdh17 |
protocadherin 17 |
decreases expression |
ISO |
Sulindac results in decreased expression of PCDH17 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr15:60,222,088...60,316,172
Ensembl chr15:60,222,004...60,313,999
|
|
G |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
increases expression |
ISO |
Sulindac results in increased expression of PCK2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression multiple interactions |
ISO EXP |
Sulindac results in decreased expression of PCNA protein epigallocatechin gallate promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein]]; kaempferol promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein]]; Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein] |
CTD |
PMID:15020200 PMID:29999212 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PDGFA mRNA |
CTD |
PMID:20371263 |
|
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
|
|
G |
Pdlim7 |
PDZ and LIM domain 7 |
increases expression |
ISO |
Sulindac results in increased expression of PDLIM7 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr17:9,124,565...9,139,814
Ensembl chr17:9,124,649...9,139,811
|
|
G |
Per1 |
period circadian regulator 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of PER1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
|
|
G |
Pex2 |
peroxisomal biogenesis factor 2 |
increases expression |
EXP |
Sulindac results in increased expression of PEX2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:96,050,380...96,072,928
Ensembl chr 2:96,045,958...96,073,404
|
|
G |
Pfdn6 |
prefoldin subunit 6 |
increases expression |
EXP |
Sulindac results in increased expression of PFDN6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:4,945,959...4,947,433
Ensembl chr20:4,945,959...4,947,433
|
|
G |
Pgap2 |
post-GPI attachment to proteins 2 |
decreases expression |
EXP |
Sulindac results in decreased expression of PGAP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:156,591,540...156,618,116
Ensembl chr 1:156,591,615...156,618,114
|
|
G |
Pi4k2b |
phosphatidylinositol 4-kinase type 2 beta |
increases expression |
EXP |
Sulindac results in increased expression of PI4K2B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:58,221,790...58,248,716
Ensembl chr14:58,220,437...58,248,673
|
|
G |
Pi4ka |
phosphatidylinositol 4-kinase alpha |
increases expression |
EXP |
Sulindac results in increased expression of PI4KA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:83,609,148...83,726,876
Ensembl chr11:83,609,069...83,724,080
|
|
G |
Pigc |
phosphatidylinositol glycan anchor biosynthesis, class C |
increases expression |
EXP |
Sulindac results in increased expression of PIGC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:74,343,619...74,346,148
Ensembl chr13:74,296,854...74,346,211
|
|
G |
Pigy |
phosphatidylinositol glycan anchor biosynthesis, class Y |
increases expression |
EXP |
Sulindac results in increased expression of PIGY mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:20,689,621...20,691,863
Ensembl chr 8:20,689,502...20,692,585
|
|
G |
Pisd |
phosphatidylserine decarboxylase |
decreases expression |
EXP |
Sulindac results in decreased expression of PISD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:77,941,927...77,991,021
Ensembl chr14:77,941,948...77,991,003
|
|
G |
Pithd1 |
PITH domain containing 1 |
increases expression |
EXP |
Sulindac results in increased expression of PITHD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:148,205,995...148,216,490
Ensembl chr 5:148,205,998...148,217,080
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
increases expression |
ISO |
Sulindac results in increased expression of PKD1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr10:13,573,779...13,621,138
Ensembl chr10:13,573,021...13,621,128
|
|
G |
Pla2g4a |
phospholipase A2 group 4A |
multiple interactions decreases expression |
ISO |
Sulindac inhibits the reaction [PLA2G4A gene mutant form results in decreased expression of SOD1 protein] Sulindac results in decreased expression of PLA2G4A mRNA |
CTD |
PMID:10706128 PMID:15816863 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Plat |
plasminogen activator, tissue type |
multiple interactions |
ISO |
[Sulindac co-treated with epigallocatechin gallate] results in decreased expression of PLAT mRNA |
CTD |
PMID:12628509 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PLCG1 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Plec |
plectin |
increases expression |
EXP |
Sulindac results in increased expression of PLEC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:107,887,764...107,949,100
Ensembl chr 7:107,887,764...107,945,467
|
|
G |
Plekhb2 |
pleckstrin homology domain containing B2 |
decreases expression |
EXP |
Sulindac results in decreased expression of PLEKHB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:37,049,580...37,082,231
Ensembl chr 9:37,038,751...37,082,231
|
|
G |
Plekhf1 |
pleckstrin homology and FYVE domain containing 1 |
increases expression |
ISO |
Sulindac results in increased expression of PLEKHF1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 1:90,908,304...90,915,862
Ensembl chr 1:90,904,742...90,915,820
|
|
G |
Plxna3 |
plexin A3 |
increases expression |
ISO |
Sulindac results in increased expression of PLXNA3 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr X:152,115,699...152,131,608
Ensembl chr X:152,115,819...152,131,603
|
|
G |
Pml |
PML nuclear body scaffold |
increases expression |
ISO |
Sulindac results in increased expression of PML mRNA |
CTD |
PMID:16273229 |
|
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
|
|
G |
Pole4 |
DNA polymerase epsilon 4, accessory subunit |
decreases expression |
EXP |
Sulindac results in decreased expression of POLE4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:115,165,285...115,171,097
Ensembl chr 4:115,165,285...115,171,097
|
|
G |
Polr2c |
RNA polymerase II subunit C |
decreases expression |
EXP |
Sulindac results in decreased expression of POLR2C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:10,158,153...10,164,935
Ensembl chr19:10,157,823...10,164,945
|
|
G |
Pomp |
proteasome maturation protein |
decreases expression |
EXP |
Sulindac results in decreased expression of POMP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:7,162,098...7,174,737
Ensembl chr12:7,160,714...7,174,715
|
|
G |
Pon3 |
paraoxonase 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of PON3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
increases expression affects response to substance |
ISO |
Sulindac results in increased expression of PPARD protein PPARD protein affects the susceptibility to Sulindac |
CTD |
PMID:10866668 PMID:21400612 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Ppp2cb |
protein phosphatase 2 catalytic subunit beta |
increases expression |
EXP |
Sulindac results in increased expression of PPP2CB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:58,558,119...58,579,325
Ensembl chr16:58,558,122...58,579,576
|
|
G |
Ppp6r1 |
protein phosphatase 6, regulatory subunit 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of PPP6R1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:69,190,856...69,217,598
Ensembl chr 1:69,189,822...69,216,272
|
|
G |
Ppt1 |
palmitoyl-protein thioesterase 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of PPT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:135,121,164...135,142,048
Ensembl chr 5:135,121,163...135,142,048
|
|
G |
Prdm15 |
PR/SET domain 15 |
increases expression |
EXP |
Sulindac results in increased expression of PRDM15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:37,164,608...37,225,172
Ensembl chr11:37,165,575...37,222,207
|
|
G |
Prdx1 |
peroxiredoxin 1 |
increases expression |
EXP |
Sulindac results in increased expression of PRDX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prkaa2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PRKAA2 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PRKACA mRNA |
CTD |
PMID:20371263 |
|
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Prkacb |
protein kinase cAMP-activated catalytic subunit beta |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PRKACB mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 2:235,636,878...235,726,928
Ensembl chr 2:235,636,885...235,726,198
|
|
G |
Prkci |
protein kinase C, iota |
increases expression |
EXP |
Sulindac results in increased expression of PRKCI mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:112,321,919...112,382,305
Ensembl chr 2:112,321,929...112,382,352
|
|
G |
Prodh |
proline dehydrogenase |
decreases expression |
EXP |
Sulindac results in decreased expression of PRODH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:82,910,043...82,927,305
Ensembl chr11:82,910,137...82,927,305
|
|
G |
Prorp |
protein only RNase P catalytic subunit |
increases expression |
EXP |
Sulindac results in increased expression of PRORP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:72,669,659...72,762,419
Ensembl chr 6:72,670,847...72,762,416
|
|
G |
Psma5 |
proteasome 20S subunit alpha 5 |
decreases expression |
EXP |
Sulindac results in decreased expression of PSMA5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:195,896,365...195,919,731
|
|
G |
Psmb5 |
proteasome 20S subunit beta 5 |
increases expression |
EXP |
Sulindac results in increased expression of PSMB5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440
|
|
G |
Psmc2 |
proteasome 26S subunit, ATPase 2 |
increases expression |
EXP |
Sulindac results in increased expression of PSMC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:13,255,850...13,270,160
Ensembl chr 4:13,255,856...13,270,185
|
|
G |
Psmc5 |
proteasome 26S subunit, ATPase 5 |
decreases expression |
EXP |
Sulindac results in decreased expression of PSMC5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:91,187,763...91,193,697
Ensembl chr10:91,187,743...91,213,135
|
|
G |
Psmc6 |
proteasome 26S subunit, ATPase 6 |
increases expression |
EXP |
Sulindac results in increased expression of PSMC6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:18,542,585...18,564,057
Ensembl chr15:18,542,563...18,564,055
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
decreases expression increases expression |
EXP |
Sulindac results in decreased expression of PTGS1 mRNA alternative form Sulindac results in increased expression of PTGS1 mRNA |
CTD |
PMID:11375891 PMID:12586211 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression increases expression decreases activity |
ISO EXP |
[Sulindac co-treated with Deferoxamine] results in increased expression of PTGS2 protein; Sulindac inhibits the reaction [Mitomycin results in increased expression of PTGS2 protein]; Sulindac inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; Sulindac promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein] Sulindac results in decreased expression of PTGS2 protein Sulindac results in increased expression of PTGS2 mRNA [Olive Oil co-treated with Sulindac] results in decreased expression of PTGS2 protein; epigallocatechin gallate promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PTGS2 protein]]; Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PTGS2 protein] Sulindac results in decreased activity of PTGS2 protein Sulindac results in decreased expression of PTGS2 mRNA |
CTD |
PMID:10706128 PMID:11375891 PMID:11504793 PMID:11910360 PMID:12586211 PMID:15309441 PMID:15489888 PMID:15793875 PMID:21882223 PMID:29999212 More...
|
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptp4a2 |
protein tyrosine phosphatase 4A2 |
increases expression |
EXP |
Sulindac results in increased expression of PTP4A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:142,165,405...142,192,412
Ensembl chr 5:142,165,700...142,191,899
|
|
G |
Ptprn |
protein tyrosine phosphatase, receptor type, N |
decreases expression |
EXP |
Sulindac results in decreased expression of PTPRN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:76,741,010...76,756,704
Ensembl chr 9:76,741,016...76,756,190
|
|
G |
Pus10 |
pseudouridine synthase 10 |
increases expression |
EXP |
Sulindac results in increased expression of PUS10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:97,621,228...97,684,059
Ensembl chr14:97,621,391...97,684,046
|
|
G |
Qtrt1 |
queuine tRNA-ribosyltransferase catalytic subunit 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of QTRT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:19,965,801...19,973,843
Ensembl chr 8:19,966,336...19,973,837
|
|
G |
Rab28 |
RAB28, member RAS oncogene family |
increases expression |
EXP |
Sulindac results in increased expression of RAB28 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:69,245,846...69,322,968
Ensembl chr14:69,245,854...69,322,967
|
|
G |
Rab2b |
RAB2B, member RAS oncogene family |
increases expression |
EXP |
Sulindac results in increased expression of RAB2B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:24,968,364...24,988,990
Ensembl chr15:24,968,803...24,989,113
|
|
G |
Rac2 |
Rac family small GTPase 2 |
decreases expression |
EXP |
Sulindac results in decreased expression of RAC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
|
|
G |
Ramac |
RNA guanine-7 methyltransferase activating subunit |
decreases expression |
EXP |
Sulindac results in decreased expression of RAMAC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:135,708,529...135,714,417
Ensembl chr 1:135,708,535...135,722,151
|
|
G |
Rasa1 |
RAS p21 protein activator 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of RASA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:15,857,704...15,940,757
Ensembl chr 2:15,857,980...15,940,854
|
|
G |
Rassf6 |
Ras association domain family member 6 |
increases expression |
EXP |
Sulindac results in increased expression of RASSF6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:17,433,328...17,473,565
Ensembl chr14:17,442,789...17,473,330
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases expression |
ISO |
Sulindac results in decreased expression of RB1 protein |
CTD |
PMID:16488075 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbbp7 |
RB binding protein 7, chromatin remodeling factor |
increases expression |
EXP |
Sulindac results in increased expression of RBBP7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:31,913,080...31,931,245
Ensembl chr X:31,913,081...31,931,226
|
|
G |
Rbm42 |
RNA binding motif protein 42 |
decreases expression |
EXP |
Sulindac results in decreased expression of RBM42 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:85,898,618...85,908,569
Ensembl chr 1:85,898,625...85,908,573
|
|
G |
Rbm45 |
RNA binding motif protein 45 |
increases expression |
EXP |
Sulindac results in increased expression of RBM45 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:61,305,973...61,320,950
Ensembl chr 3:61,305,924...61,320,952
|
|
G |
Rbm47 |
RNA binding motif protein 47 |
decreases expression |
EXP |
Sulindac results in decreased expression of RBM47 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:42,053,290...42,191,572
Ensembl chr14:42,154,142...42,189,431
|
|
G |
Rbx1 |
ring-box 1 |
increases expression |
EXP |
Sulindac results in increased expression of RBX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:112,976,863...113,001,051
Ensembl chr 7:112,990,835...113,001,051
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
affects localization multiple interactions increases expression increases activity |
ISO |
Sulindac affects the localization of RELA protein [[Sulindac co-treated with Arsenic Trioxide] results in decreased phosphorylation of and results in decreased degradation of NFKBIA protein] which affects the localization of RELA protein; Sulindac inhibits the reaction [Lipopolysaccharides results in increased expression of RELA protein]; Sulindac inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; Sulindac inhibits the reaction [TNF protein results in increased activity of RELA protein] Sulindac results in increased expression of RELA mRNA Sulindac results in increased activity of RELA protein |
CTD |
PMID:10328874 PMID:15489888 PMID:16159934 PMID:16273229 PMID:18059344 PMID:18575716 More...
|
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ren |
renin |
multiple interactions decreases activity |
ISO |
Sulindac inhibits the reaction [Furosemide results in increased expression of REN protein] Sulindac results in decreased activity of REN protein |
CTD |
PMID:2203262 PMID:3884224 PMID:4028619 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Ret |
ret proto-oncogene |
affects expression |
ISO |
Sulindac affects the expression of RET protein |
CTD |
PMID:12388792 |
|
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
|
|
G |
RGD1311745 |
similar to RIKEN cDNA 1110059G10 |
increases expression |
EXP |
Sulindac results in increased expression of RGD1311745 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:122,598,363...122,609,127
Ensembl chr 8:122,598,401...122,609,168
|
|
G |
Rgp1 |
RGP1 homolog, RAB6A GEF complex partner 1 |
increases expression |
EXP |
Sulindac results in increased expression of RGP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:57,834,467...57,843,087
Ensembl chr 5:57,834,629...57,843,086
|
|
G |
Rmdn3 |
regulator of microtubule dynamics 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of RMDN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:106,125,961...106,146,568
Ensembl chr 3:106,125,951...106,146,586
|
|
G |
Rnase1 |
ribonuclease A family member 1, pancreatic |
decreases expression |
ISO |
Sulindac results in decreased expression of RNASE1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr15:24,361,924...24,363,633
Ensembl chr15:24,361,927...24,363,624
|
|
G |
Rnf220 |
ring finger protein 220 |
increases expression |
EXP |
Sulindac results in increased expression of RNF220 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:130,739,173...130,961,386
Ensembl chr 5:130,739,183...130,961,418
|
|
G |
Rnf26 |
ring finger protein 26 |
decreases expression |
ISO |
Sulindac results in decreased expression of RNF26 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 8:44,454,551...44,456,745
Ensembl chr 8:44,454,292...44,457,331
|
|
G |
Rnpepl1 |
arginyl aminopeptidase like 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of RNPEPL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:93,476,600...93,486,331
Ensembl chr 9:93,472,390...93,486,331
|
|
G |
Rpia |
ribose 5-phosphate isomerase A |
decreases expression |
EXP |
Sulindac results in decreased expression of RPIA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:102,723,712...102,749,374
Ensembl chr 4:102,723,712...102,749,355
|
|
G |
Rragc |
Ras-related GTP binding C |
decreases expression |
EXP |
Sulindac results in decreased expression of RRAGC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:136,148,239...136,167,773
Ensembl chr 5:136,148,276...136,167,767
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of RXRA mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Sae1 |
SUMO1 activating enzyme subunit 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of SAE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:77,030,961...77,086,937
Ensembl chr 1:77,030,965...77,086,986
|
|
G |
Sap30l |
SAP30-like |
decreases expression |
EXP |
Sulindac results in decreased expression of SAP30L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:41,979,730...41,992,307
Ensembl chr10:41,979,687...41,987,658
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
increases expression |
ISO |
Sulindac results in increased expression of SAT1 mRNA |
CTD |
PMID:14506281 PMID:16262603 |
|
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
|
|
G |
Sat2 |
spermidine/spermine N1-acetyltransferase family member 2 |
increases activity increases expression |
ISO |
Sulindac results in increased activity of SAT2 protein Sulindac results in increased expression of SAT2 mRNA |
CTD |
PMID:17474863 |
|
NCBI chr10:54,340,756...54,343,507
Ensembl chr10:54,340,372...54,343,224
|
|
G |
Scamp1 |
secretory carrier membrane protein 1 |
increases expression |
EXP |
Sulindac results in increased expression of SCAMP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:25,433,958...25,516,734
Ensembl chr 2:25,433,959...25,516,673
|
|
G |
Sco1 |
synthesis of cytochrome C oxidase 1 |
increases expression |
EXP |
Sulindac results in increased expression of SCO1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:51,744,656...51,757,246
Ensembl chr10:51,744,656...51,757,237
|
|
G |
Sdhaf3 |
succinate dehydrogenase complex assembly factor 3 |
increases expression |
EXP |
Sulindac results in increased expression of SDHAF3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:35,100,533...35,160,740
Ensembl chr 4:35,100,506...35,160,749
|
|
G |
Sec62 |
SEC62 homolog, preprotein translocation factor |
decreases expression |
EXP |
Sulindac results in decreased expression of SEC62 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:112,570,810...112,598,198
Ensembl chr 2:112,570,819...112,601,814
|
|
G |
Sec63 |
SEC63 homolog, protein translocation regulator |
decreases expression |
EXP |
Sulindac results in decreased expression of SEC63 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:46,245,101...46,314,055
Ensembl chr20:46,245,101...46,314,055
|
|
G |
Septin10 |
septin 10 |
decreases expression |
EXP |
Sulindac results in decreased expression of SEPTIN10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:27,101,764...27,194,997
Ensembl chr20:27,101,752...27,194,780
|
|
G |
Serpinb1a |
serpin family B member 1A |
increases expression |
ISO |
Sulindac results in increased expression of SERPINB1 mRNA |
CTD |
PMID:11507085 |
|
NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102
|
|
G |
Set |
Set nuclear proto-oncogene |
decreases expression |
EXP |
Sulindac results in decreased expression of SET mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:13,334,564...13,345,598
Ensembl chr 3:13,335,041...13,363,567
|
|
G |
Sft2d2 |
SFT2 domain containing 2 |
increases expression |
EXP |
Sulindac results in increased expression of SFT2D2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:77,484,778...77,504,123
Ensembl chr13:77,484,636...77,504,112
|
|
G |
Shc1 |
SHC adaptor protein 1 |
multiple interactions |
ISO |
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SHC1 mRNA] |
CTD |
PMID:15190207 |
|
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
|
|
G |
Shmt2 |
serine hydroxymethyltransferase 2 |
increases expression |
EXP |
Sulindac results in increased expression of SHMT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:63,358,961...63,364,293
Ensembl chr 7:63,358,961...63,364,236
|
|
G |
Sirt1 |
sirtuin 1 |
increases expression |
ISO |
Sulindac results in increased expression of SIRT1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Skic8 |
SKI8 subunit of superkiller complex |
decreases expression |
EXP |
Sulindac results in decreased expression of SKIC8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:55,103,542...55,120,837
Ensembl chr 8:55,103,545...55,120,813
|
|
G |
Slc16a6 |
solute carrier family 16, member 6 |
increases expression |
ISO |
Sulindac results in increased expression of SLC16A6 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr10:94,424,377...94,447,482
Ensembl chr10:94,426,244...94,448,779
|
|
G |
Slc18b1 |
solute carrier family 18 member B1 |
increases expression |
EXP |
Sulindac results in increased expression of SLC18B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:21,628,235...21,670,807
Ensembl chr 1:21,628,237...21,670,684
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
decreases activity |
ISO |
Sulindac results in decreased activity of SLC22A1 protein |
CTD |
PMID:12388633 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
decreases activity |
ISO |
Sulindac results in decreased activity of SLC22A2 protein |
CTD |
PMID:12388633 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a25 |
solute carrier family 22, member 25 |
decreases activity |
ISO |
Sulindac results in decreased activity of SLC22A9 protein |
CTD |
PMID:12388633 |
|
NCBI chr 1:205,338,698...205,498,486
Ensembl chr 1:205,338,699...205,433,085
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
decreases activity |
ISO |
Sulindac results in decreased activity of SLC22A6 protein |
CTD |
PMID:12388633 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a7 |
solute carrier family 22 member 7 |
decreases activity |
ISO |
Sulindac results in decreased activity of SLC22A7 protein |
CTD |
PMID:12388633 |
|
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
|
|
G |
Slc27a4 |
solute carrier family 27 member 4 |
decreases expression |
EXP |
Sulindac results in decreased expression of SLC27A4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:13,075,022...13,087,943
Ensembl chr 3:13,075,022...13,087,943
|
|
G |
Slc30a1 |
solute carrier family 30 member 1 |
increases expression |
ISO |
Sulindac results in increased expression of SLC30A1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
|
|
G |
Slc30a5 |
solute carrier family 30 member 5 |
decreases expression |
EXP |
Sulindac results in decreased expression of SLC30A5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:31,945,745...31,975,969
Ensembl chr 2:31,945,729...31,975,934
|
|
G |
Slc38a2 |
solute carrier family 38, member 2 |
increases expression |
ISO |
Sulindac results in increased expression of SLC38A2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
increases expression |
ISO |
Sulindac results in increased expression of SLC3A2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Slc4a1ap |
solute carrier family 4 member 1 adaptor protein |
decreases expression |
EXP |
Sulindac results in decreased expression of SLC4A1AP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:24,905,941...24,933,651
Ensembl chr 6:24,905,941...24,933,815
|
|
G |
Slc7a1 |
solute carrier family 7 member 1 |
increases expression |
ISO |
Sulindac results in increased expression of SLC7A1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of SLCO1A2 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
|
|
G |
Slfn3 |
schlafen family member 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of SLFN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:68,020,482...68,060,248
|
|
G |
Smc1a |
structural maintenance of chromosomes 1A |
decreases expression |
EXP |
Sulindac results in decreased expression of SMC1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:21,103,323...21,148,053
Ensembl chr X:21,103,282...21,148,056
|
|
G |
Smu1 |
SMU1, DNA replication regulator and spliceosomal factor |
decreases expression |
EXP |
Sulindac results in decreased expression of SMU1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:55,856,691...55,875,262
Ensembl chr 5:55,856,246...55,875,300
|
|
G |
Snrnp27 |
small nuclear ribonucleoprotein U4/U6.U5 subunit 27 |
increases expression |
EXP |
Sulindac results in increased expression of SNRNP27 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:119,123,676...119,133,234
Ensembl chr 4:119,121,877...119,133,234
|
|
G |
Snx21 |
sorting nexin family member 21 |
increases expression |
ISO |
Sulindac results in increased expression of SNX21 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 3:153,522,474...153,532,235
Ensembl chr 3:153,522,486...153,532,221
|
|
G |
Snx25 |
sorting nexin 25 |
increases expression |
ISO |
Sulindac results in increased expression of SNX25 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr16:46,134,552...46,238,471
Ensembl chr16:46,125,804...46,238,440
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
Sulindac inhibits the reaction [PLA2G4A gene mutant form results in decreased expression of SOD1 protein] |
CTD |
PMID:15816863 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SOD2 mRNA] |
CTD |
PMID:15190207 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spred3 |
sprouty-related, EVH1 domain containing 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of SPRED3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:84,458,779...84,470,425
Ensembl chr 1:84,459,314...84,470,249
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
Sulindac results in increased expression of SQSTM1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions |
EXP ISO |
[[Azoxymethane co-treated with Sulindac] results in increased expression of CSK protein] which results in increased phosphorylation of and results in decreased activity of SRC protein Sulindac results in increased phosphorylation of and results in decreased activity of SRC protein |
CTD |
PMID:18644992 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
Sulindac results in increased expression of SRXN1 protein |
CTD |
PMID:27358234 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Ss18 |
SS18 subunit of BAF chromatin remodeling complex |
decreases expression |
EXP |
Sulindac results in decreased expression of SS18 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:5,773,042...5,835,696
Ensembl chr18:5,773,042...5,835,333
|
|
G |
Ssu72 |
SSU72 homolog, RNA polymerase II CTD phosphatase |
decreases expression |
EXP |
Sulindac results in decreased expression of SSU72 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:166,312,267...166,343,432
Ensembl chr 5:166,313,650...166,343,429
|
|
G |
Stac3 |
SH3 and cysteine rich domain 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of STAC3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:63,343,078...63,350,590
Ensembl chr 7:63,343,186...63,350,589
|
|
G |
Stard3 |
StAR-related lipid transfer domain containing 3 |
increases expression |
EXP |
Sulindac results in increased expression of STARD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:83,357,329...83,379,873
Ensembl chr10:83,357,359...83,550,976
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions decreases phosphorylation decreases expression |
ISO |
BIRC5 protein inhibits the reaction [Sulindac results in decreased expression of STAT3 protein modified form]; BIRC5 protein inhibits the reaction [Sulindac results in decreased expression of STAT3 protein] Sulindac results in decreased phosphorylation of STAT3 protein Sulindac results in decreased expression of STAT3 protein; Sulindac results in decreased expression of STAT3 protein modified form |
CTD |
PMID:11861373 PMID:17401459 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stc2 |
stanniocalcin 2 |
increases expression |
ISO |
Sulindac results in increased expression of STC2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
|
|
G |
Stoml2 |
stomatin like 2 |
increases expression |
EXP |
Sulindac results in increased expression of STOML2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:57,256,227...57,259,824
Ensembl chr 5:57,256,220...57,259,920
|
|
G |
Strbp |
spermatid perinuclear RNA binding protein |
increases expression |
EXP |
Sulindac results in increased expression of STRBP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:21,328,310...21,467,753
Ensembl chr 3:21,337,855...21,414,949
|
|
G |
Stx7 |
syntaxin 7 |
decreases expression |
EXP |
Sulindac results in decreased expression of STX7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:21,197,075...21,237,320
Ensembl chr 1:21,197,075...21,237,279
|
|
G |
Stxbp2 |
syntaxin binding protein 2 |
increases expression |
ISO |
Sulindac results in increased expression of STXBP2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr12:1,689,364...1,701,145
Ensembl chr12:1,689,410...1,700,458
|
|
G |
Suclg1 |
succinate-CoA ligase GDP/ADP-forming subunit alpha |
increases expression |
EXP |
Sulindac results in increased expression of SUCLG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:105,308,236...105,337,595
Ensembl chr 4:105,308,039...105,337,600
|
|
G |
Sult1b1 |
sulfotransferase family 1B member 1 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of SULT1B1 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,492,708...20,505,483
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
multiple interactions decreases activity |
EXP ISO |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of SULT1E1 mRNA Sulindac results in decreased activity of SULT1E1 protein |
CTD |
PMID:17073578 PMID:20371263 |
|
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
|
|
G |
Sumo3 |
small ubiquitin-like modifier 3 |
decreases expression |
ISO |
Sulindac results in decreased expression of SUMO3 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr20:11,010,140...11,020,850
Ensembl chr20:11,007,148...11,020,877 Ensembl chr20:11,007,148...11,020,877
|
|
G |
Sun2 |
Sad1 and UNC84 domain containing 2 |
decreases expression |
ISO |
Sulindac results in decreased expression of SUN2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 7:111,275,374...111,292,565
Ensembl chr 7:111,275,380...111,292,553
|
|
G |
Supt7l |
SPT7 like, STAGA complex subunit gamma |
decreases expression |
EXP |
Sulindac results in decreased expression of SUPT7L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:24,933,941...24,944,656
Ensembl chr 6:24,933,923...24,944,654
|
|
G |
Syp |
synaptophysin |
decreases expression |
EXP |
Sulindac results in decreased expression of SYP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:14,849,444...14,864,553
Ensembl chr X:14,849,444...14,864,745
|
|
G |
Syt15 |
synaptotagmin 15 |
decreases expression |
EXP |
Sulindac results in decreased expression of SYT15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:9,532,478...9,543,288
Ensembl chr16:9,532,478...9,543,281
|
|
G |
Tbc1d10b |
TBC1 domain family, member 10b |
increases expression |
ISO |
Sulindac results in increased expression of TBC1D10B mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 1:181,814,972...181,826,628
Ensembl chr 1:181,814,972...181,826,628
|
|
G |
Tbk1 |
TANK-binding kinase 1 |
increases expression |
ISO |
Sulindac results in increased expression of TBK1 mRNA |
CTD |
PMID:11093808 |
|
NCBI chr 7:57,077,830...57,110,868
Ensembl chr 7:57,077,830...57,110,892
|
|
G |
Tbx3 |
T-box transcription factor 3 |
increases expression |
ISO |
Sulindac results in increased expression of TBX3 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
|
|
G |
Tceanc2 |
transcription elongation factor A N-terminal and central domain containing 2 |
increases expression |
EXP |
Sulindac results in increased expression of TCEANC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:121,923,959...121,963,018
Ensembl chr 5:121,923,956...121,962,183
|
|
G |
Tcf4 |
transcription factor 4 |
decreases activity multiple interactions |
ISO |
Sulindac results in decreased activity of TCF4 protein TCF4 protein promotes the reaction [Sulindac results in increased susceptibility to TNFSF10 protein] |
CTD |
PMID:11593435 PMID:21171083 |
|
NCBI chr18:62,941,739...63,288,126
Ensembl chr18:62,943,782...63,284,425
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
decreases activity multiple interactions |
EXP |
Sulindac results in decreased activity of TDO2 protein [Sulindac results in decreased activity of TDO2 protein] which results in decreased abundance of Dopamine; [Sulindac results in decreased activity of TDO2 protein] which results in increased abundance of Serotonin |
CTD |
PMID:16952380 |
|
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
G |
Tek |
TEK receptor tyrosine kinase |
multiple interactions |
ISO |
Sulindac analog results in decreased phosphorylation of and results in decreased activity of TEK protein |
CTD |
PMID:16215210 |
|
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
|
|
G |
Tfdp1 |
transcription factor Dp-1 |
decreases expression |
EXP |
Sulindac results in decreased expression of TFDP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:76,162,040...76,200,871
Ensembl chr16:76,162,043...76,200,817
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression |
ISO |
Sulindac results in increased expression of TGFB1 protein |
CTD |
PMID:11496082 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgm2 |
transglutaminase 2 |
multiple interactions |
ISO |
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of TGM2 mRNA] |
CTD |
PMID:15190207 |
|
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
|
|
G |
Thap7 |
THAP domain containing 7 |
increases expression |
EXP |
Sulindac results in increased expression of THAP7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:83,482,958...83,486,136
Ensembl chr11:83,483,037...83,486,436
|
|
G |
Thrsp |
thyroid hormone responsive |
decreases expression |
EXP |
Sulindac results in decreased expression of THRSP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G |
Timm10 |
translocase of inner mitochondrial membrane 10 |
increases expression |
EXP |
Sulindac results in increased expression of TIMM10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:69,908,397...69,911,943
Ensembl chr 3:69,908,456...69,911,940
|
|
G |
Timmdc1 |
translocase of inner mitochondrial membrane domain containing 1 |
increases expression |
EXP |
Sulindac results in increased expression of TIMMDC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:62,228,990...62,259,389
Ensembl chr11:62,229,058...62,254,699
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
affects expression |
ISO |
Sulindac affects the expression of TIMP1 protein |
CTD |
PMID:12388792 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
multiple interactions |
ISO |
[Sulindac co-treated with epigallocatechin gallate] results in decreased expression of TIMP3 mRNA |
CTD |
PMID:12628509 |
|
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Tjp2 |
tight junction protein 2 |
increases expression |
EXP |
Sulindac results in increased expression of TJP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:221,709,745...221,838,291
Ensembl chr 1:221,709,745...221,838,295
|
|
G |
Tlr2 |
toll-like receptor 2 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of TLR2 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tm2d1 |
TM2 domain containing 1 |
increases expression |
EXP |
Sulindac results in increased expression of TM2D1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:113,020,793...113,062,134
Ensembl chr 5:113,020,760...113,050,933
|
|
G |
Tm7sf3 |
transmembrane 7 superfamily member 3 |
decreases expression |
ISO |
Sulindac results in decreased expression of TM7SF3 mRNA |
CTD |
PMID:11093808 |
|
NCBI chr 4:179,518,127...179,550,154
Ensembl chr 4:179,518,130...179,550,154
|
|
G |
Tmed9 |
transmembrane p24 trafficking protein 9 |
decreases expression |
ISO |
Sulindac results in decreased expression of TMED9 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr17:9,029,646...9,034,160
Ensembl chr17:9,029,646...9,034,176
|
|
G |
Tmem127 |
transmembrane protein 127 |
increases expression |
ISO |
Sulindac results in increased expression of TMEM127 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 3:114,466,095...114,478,894
Ensembl chr 3:114,466,171...114,477,519
|
|
G |
Tmem141 |
transmembrane protein 141 |
increases expression |
EXP |
Sulindac results in increased expression of TMEM141 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:8,439,533...8,441,491
Ensembl chr 3:8,439,533...8,441,491
|
|
G |
Tmem209 |
transmembrane protein 209 |
decreases expression |
EXP |
Sulindac results in decreased expression of TMEM209 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:59,102,943...59,128,636
Ensembl chr 4:59,101,550...59,128,630
|
|
G |
Tmem39a |
transmembrane protein 39a |
increases expression |
ISO |
Sulindac results in increased expression of TMEM39A mRNA |
CTD |
PMID:11906190 |
|
NCBI chr11:62,160,631...62,189,964
Ensembl chr11:62,160,631...62,189,964
|
|
G |
Tmem60 |
transmembrane protein 60 |
increases expression |
EXP |
Sulindac results in increased expression of TMEM60 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:14,210,029...14,214,884
Ensembl chr 4:14,210,029...14,215,063
|
|
G |
Tmx1 |
thioredoxin-related transmembrane protein 1 |
increases expression |
EXP |
Sulindac results in increased expression of TMX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:88,960,691...88,971,744
Ensembl chr 6:88,960,695...88,971,301
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
Sulindac inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Sulindac inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; Sulindac inhibits the reaction [TNF protein results in increased activity of CHUK protein]; Sulindac inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]; Sulindac inhibits the reaction [TNF protein results in increased activity of RELA protein]; Sulindac inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; Sulindac inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; Sulindac inhibits the reaction [TNF protein results in increased expression of CCND1 protein]; Sulindac inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] [Sulindac co-treated with Lipopolysaccharides] results in increased secretion of TNF protein; Sulindac inhibits the reaction [Okadaic Acid results in increased expression of TNF protein] Sulindac results in increased expression of TNF |
CTD |
PMID:10328874 PMID:10757128 PMID:15489888 PMID:16159934 PMID:17328244 PMID:24136188 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
increases response to substance multiple interactions |
ISO |
Sulindac results in increased susceptibility to TNFSF10 protein [Sulindac co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; TCF4 protein promotes the reaction [Sulindac results in increased susceptibility to TNFSF10 protein] |
CTD |
PMID:21171083 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tns3 |
tensin 3 |
decreases expression |
ISO |
Sulindac results in decreased expression of TNS3 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr14:83,173,649...83,405,671
Ensembl chr14:83,173,649...83,405,998
|
|
G |
Tor1a |
torsin family 1, member A |
decreases expression |
EXP |
Sulindac results in decreased expression of TOR1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:14,250,667...14,257,704
Ensembl chr 3:14,250,676...14,257,691
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions affects localization increases expression decreases expression |
ISO |
[Sulindac results in increased abundance of Reactive Oxygen Species] which results in increased activity of TP53 protein; SB 203580 inhibits the reaction [Sulindac affects the localization of TP53 protein] Sulindac results in increased expression of TP53 protein Sulindac results in decreased expression of TRP53 protein |
CTD |
PMID:15020200 PMID:15713900 PMID:17136320 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpra1 |
transmembrane protein adipocyte associated 1 |
increases expression |
ISO |
Sulindac results in increased expression of TPRA1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 4:121,364,093...121,375,275
Ensembl chr 4:121,364,091...121,375,269
|
|
G |
Trim2 |
tripartite motif-containing 2 |
increases expression |
ISO |
Sulindac results in increased expression of TRIM2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
|
|
G |
Trit1 |
tRNA isopentenyltransferase 1 |
decreases expression |
ISO |
Sulindac results in decreased expression of TRIT1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 5:135,293,472...135,341,522
Ensembl chr 5:135,295,330...135,338,764
|
|
G |
Trub2 |
TruB pseudouridine synthase family member 2 |
increases expression |
EXP |
Sulindac results in increased expression of TRUB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:13,049,220...13,059,836
Ensembl chr 3:13,033,745...13,059,930
|
|
G |
Tsnax |
translin-associated factor X |
decreases expression |
ISO |
Sulindac results in decreased expression of TSNAX mRNA |
CTD |
PMID:11906190 |
|
NCBI chr19:52,975,848...52,989,886
Ensembl chr19:52,975,659...52,989,878
|
|
G |
Tusc2 |
tumor suppressor 2, mitochondrial calcium regulator |
increases expression |
EXP |
Sulindac results in increased expression of TUSC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,236,838...108,240,056
Ensembl chr 8:108,236,838...108,240,056
|
|
G |
Txn1 |
thioredoxin 1 |
increases response to substance |
ISO |
TXN1 results in increased susceptibility to Sulindac analog |
CTD |
PMID:18922898 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txnl1 |
thioredoxin-like 1 |
increases expression |
EXP |
Sulindac results in increased expression of TXNL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:57,125,362...57,155,167
Ensembl chr18:57,125,369...57,165,266
|
|
G |
Tyw1 |
tRNA-yW synthesizing protein 1 homolog |
increases expression |
EXP |
Sulindac results in increased expression of TYW1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:26,332,020...26,418,286
Ensembl chr12:26,330,351...26,418,208
|
|
G |
Ube2e3 |
ubiquitin-conjugating enzyme E2E 3 |
decreases expression |
EXP |
Sulindac results in decreased expression of UBE2E3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:63,786,976...63,851,400
Ensembl chr 3:63,786,650...63,843,237
|
|
G |
Ube3a |
ubiquitin protein ligase E3A |
increases expression |
EXP |
Sulindac results in increased expression of UBE3A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:110,070,260...110,161,675
Ensembl chr 1:110,070,480...110,157,250
|
|
G |
Ubl5 |
ubiquitin-like 5 |
decreases expression |
EXP |
Sulindac results in decreased expression of UBL5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:19,181,504...19,185,224
Ensembl chr 8:19,181,615...19,185,217
|
|
G |
Ubqln2 |
ubiquilin 2 |
increases expression |
EXP |
Sulindac results in increased expression of UBQLN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:17,853,086...17,856,505
Ensembl chr X:17,853,114...17,856,505
|
|
G |
Ufd1 |
ubiquitin recognition factor in ER associated degradation 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of UFD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:82,161,618...82,185,107
Ensembl chr11:82,161,619...82,185,087
|
|
G |
Ufl1 |
Ufm1-specific ligase 1 |
increases expression |
EXP |
Sulindac results in increased expression of UFL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:38,962,721...38,995,134
Ensembl chr 5:38,962,171...38,995,199
|
|
G |
Uggt2 |
UDP-glucose glycoprotein glucosyltransferase 2 |
increases expression |
ISO |
Sulindac results in increased expression of UGGT2 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr15:96,074,557...96,239,365
Ensembl chr15:96,074,564...96,237,806
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases activity increases expression increases glucuronidation |
ISO |
Sulindac results in increased activity of UGT1A1 protein Sulindac results in increased expression of UGT1A1 mRNA UGT1A1 protein results in increased glucuronidation of Sulindac |
CTD |
PMID:15843492 PMID:17985343 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
increases glucuronidation |
ISO |
UGT1A3 protein results in increased glucuronidation of Sulindac |
CTD |
PMID:15843492 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
increases glucuronidation |
ISO |
UGT1A4 protein results in increased glucuronidation of Sulindac |
CTD |
PMID:15843492 |
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
increases glucuronidation |
ISO |
UGT2B7 protein results in increased glucuronidation of Sulindac |
CTD |
PMID:15843492 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Ung |
uracil-DNA glycosylase |
decreases expression |
ISO |
Sulindac results in decreased expression of UNG mRNA |
CTD |
PMID:11906190 |
|
NCBI chr12:42,485,276...42,494,217
Ensembl chr12:42,485,276...42,494,206
|
|
G |
Uqcc2 |
ubiquinol-cytochrome c reductase complex assembly factor 2 |
decreases expression |
EXP |
Sulindac results in decreased expression of UQCC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:5,202,837...5,214,541
Ensembl chr20:5,202,837...5,214,164
|
|
G |
Uqcc4 |
ubiquinol-cytochrome c reductase complex assembly factor 4 |
increases expression |
EXP |
Sulindac results in increased expression of UQCC4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:14,202,217...14,203,519
Ensembl chr10:14,202,243...14,204,029
|
|
G |
Vapb |
VAMP associated protein B and C |
increases expression |
EXP |
Sulindac results in increased expression of VAPB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:162,535,974...162,578,747
Ensembl chr 3:162,535,905...162,573,763
|
|
G |
Vash1 |
vasohibin 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of VASH1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:106,330,374...106,345,740
Ensembl chr 6:106,329,123...106,345,726
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of VCAM1 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vcp |
valosin-containing protein |
decreases expression |
EXP |
Sulindac results in decreased expression of VCP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:57,210,167...57,229,571
Ensembl chr 5:57,210,168...57,229,571
|
|
G |
Vps26b |
VPS26 retromer complex component B |
decreases expression |
EXP |
Sulindac results in decreased expression of VPS26B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:25,415,877...25,436,985
Ensembl chr 8:25,415,261...25,436,985
|
|
G |
Vps26c |
VPS26 endosomal protein sorting factor C |
increases expression |
EXP |
Sulindac results in increased expression of VPS26C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:33,813,467...33,841,883
Ensembl chr11:33,792,389...33,841,447
|
|
G |
Vps29 |
VPS29 retromer complex component |
increases expression |
EXP |
Sulindac results in increased expression of VPS29 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:34,208,911...34,217,977
Ensembl chr12:34,207,263...34,217,964
|
|
G |
Vps35 |
VPS35 retromer complex component |
decreases expression |
EXP |
Sulindac results in decreased expression of VPS35 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:21,765,771...21,801,620
Ensembl chr19:21,765,749...21,801,618
|
|
G |
Vps53 |
VPS53 subunit of GARP complex |
increases expression |
EXP |
Sulindac results in increased expression of VPS53 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:60,919,820...61,038,674
Ensembl chr10:60,919,820...61,038,676
|
|
G |
Wdr3 |
WD repeat domain 3 |
increases expression |
ISO |
Sulindac results in increased expression of WDR3 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr 2:187,505,816...187,528,432
Ensembl chr 2:187,505,816...187,528,432
|
|
G |
Wdr83os |
WD repeat domain 83 opposite strand |
increases expression |
EXP |
Sulindac results in increased expression of WDR83OS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:23,075,373...23,076,745
Ensembl chr19:23,075,376...23,076,894
|
|
G |
Wwp1 |
WW domain containing E3 ubiquitin protein ligase 1 |
decreases expression |
EXP |
Sulindac results in decreased expression of WWP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:33,092,379...33,185,887
Ensembl chr 5:33,098,494...33,186,046
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases expression |
ISO |
Sulindac results in increased expression of XBP1 mRNA |
CTD |
PMID:11906190 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
multiple interactions |
ISO |
[Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of XIAP protein |
CTD |
PMID:17136320 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Xpo1 |
exportin 1 |
multiple interactions |
EXP |
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of XPO1 mRNA |
CTD |
PMID:20371263 |
|
NCBI chr14:97,233,282...97,275,536
Ensembl chr14:97,233,270...97,275,498
|
|
G |
Xpr1 |
xenotropic and polytropic retrovirus receptor 1 |
increases expression |
EXP |
Sulindac results in increased expression of XPR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:67,441,205...67,585,950
Ensembl chr13:67,446,380...67,585,946
|
|
G |
Xrcc5 |
X-ray repair cross complementing 5 |
decreases expression |
EXP |
Sulindac results in decreased expression of XRCC5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
|
|
G |
Yme1l1 |
YME1-like 1 ATPase |
decreases expression |
EXP |
Sulindac results in decreased expression of YME1L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:85,287,607...85,326,068
Ensembl chr17:85,287,554...85,326,335
|
|
G |
Ythdf3 |
YTH N6-methyladenosine RNA binding protein F3 |
increases expression |
EXP |
Sulindac results in increased expression of YTHDF3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:98,350,304...98,384,608
Ensembl chr 2:98,350,588...98,384,606
|
|
G |
Ywhab |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
increases expression |
EXP |
Sulindac results in increased expression of YWHAB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
|
|
G |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon |
increases expression |
EXP |
Sulindac results in increased expression of YWHAE mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:60,584,665...60,622,352
Ensembl chr10:60,584,652...60,671,589
|
|
G |
Zc3h13 |
zinc finger CCCH type containing 13 |
increases expression |
EXP |
Sulindac results in increased expression of ZC3H13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:50,607,335...50,671,802
Ensembl chr15:50,607,380...50,671,802
|
|
G |
Zfp106 |
zinc finger protein 106 |
decreases expression |
EXP |
Sulindac results in decreased expression of ZFP106 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:107,459,232...107,510,507
Ensembl chr 3:107,462,096...107,510,481
|
|
G |
Zfp148 |
zinc finger protein 148 |
decreases expression |
EXP |
Sulindac results in decreased expression of ZFP148 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:67,276,455...67,385,803
Ensembl chr11:67,281,707...67,385,772
|
|
G |
Zfp281 |
zinc finger protein 281 |
increases expression |
EXP |
Sulindac results in increased expression of ZFP281 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:48,096,103...48,104,265
Ensembl chr13:48,037,286...48,104,888
|
|
G |
Zfp354a |
zinc finger protein 354A |
increases expression |
ISO |
Sulindac results in increased expression of ZNF354A mRNA |
CTD |
PMID:11906190 |
|
NCBI chr10:35,396,242...35,408,069
Ensembl chr10:35,396,231...35,408,068
|
|
G |
Zfp423 |
zinc finger protein 423 |
decreases expression |
EXP |
Sulindac results in decreased expression of ZFP423 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:19,111,213...19,407,373
Ensembl chr19:19,110,238...19,407,373
|
|
G |
Znhit1 |
zinc finger, HIT-type containing 1 |
increases expression |
EXP |
Sulindac results in increased expression of ZNHIT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:19,686,606...19,692,880
Ensembl chr12:19,686,148...19,692,880
|
|
G |
Znhit3 |
zinc finger, HIT-type containing 3 |
increases expression |
EXP |
Sulindac results in increased expression of ZNHIT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:69,775,885...69,790,471
Ensembl chr10:69,748,789...69,790,475 Ensembl chr10:69,748,789...69,790,475
|
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
increases expression |
ISO |
sulindac sulfide results in increased expression of ABCG2 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Actn1 |
actinin, alpha 1 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of ACTN1 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Adam9 |
ADAM metallopeptidase domain 9 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of ADAM9 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
|
|
G |
Adm |
adrenomedullin |
increases expression |
ISO |
sulindac sulfide results in increased expression of ADM mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adra2c |
adrenoceptor alpha 2C |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of ADRA2C mRNA |
CTD |
PMID:12734198 |
|
NCBI chr14:75,470,884...75,472,846
Ensembl chr14:75,471,143...75,472,846
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases localization |
ISO |
sulindac sulfide results in increased localization of AHR protein |
CTD |
PMID:17985343 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
increases expression |
ISO |
sulindac sulfide results in increased expression of AKAP12 mRNA |
CTD |
PMID:12734198 |
|
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
sulindac sulfide results in increased expression of AKR1C1 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of ALDOC mRNA |
CTD |
PMID:16184548 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
increases expression |
ISO |
sulindac sulfide results in increased expression of ALOX15 protein |
CTD |
PMID:16166323 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Anxa5 |
annexin A5 |
increases expression |
ISO |
sulindac sulfide results in increased expression of ANXA5 protein |
CTD |
PMID:18678619 |
|
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Apoa1 |
apolipoprotein A1 |
multiple interactions |
ISO |
sulindac sulfide inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] |
CTD |
PMID:19013290 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions affects cleavage |
ISO EXP |
[sulindac sulfide results in decreased activity of PSEN1 protein] which affects the cleavage of APP protein; PSEN1 protein affects the reaction [sulindac sulfide affects the cleavage of APP protein]; PSEN1 protein mutant form promotes the reaction [sulindac sulfide affects the cleavage of APP protein]; sulindac sulfide affects the cleavage of and affects the localization of APP protein; sulindac sulfide affects the reaction [PSEN1 protein affects the cleavage of APP protein] sulindac sulfide inhibits the reaction [APP protein results in increased uptake of Calcium] |
CTD |
PMID:11700559 PMID:12637581 PMID:12777371 PMID:12805356 PMID:14690522 PMID:15274632 PMID:17573346 PMID:17962197 PMID:18359496 PMID:18426795 PMID:18648507 More...
|
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
AR protein affects the reaction [sulindac sulfide results in decreased expression of KLK3 protein]; sulindac sulfide results in decreased expression of and results in decreased activity of AR protein |
CTD |
PMID:14581372 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Areg |
amphiregulin |
increases expression |
ISO |
sulindac sulfide results in increased expression of AREG mRNA |
CTD |
PMID:16184548 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arl6ip1 |
ADP-ribosylation factor like GTPase 6 interacting protein 1 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of ARL6IP1 mRNA |
CTD |
PMID:12734198 |
|
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
|
|
G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of ARPC1B mRNA |
CTD |
PMID:12734198 |
|
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of ASAH1 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
|
|
G |
Atf3 |
activating transcription factor 3 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sulindac sulfide results in increased expression of ATF3 mRNA]; [sulindac sulfide results in increased phosphorylation of MAPK1 protein] which results in increased expression of ATF3 protein; [sulindac sulfide results in increased phosphorylation of MAPK3 protein] which results in increased expression of ATF3 protein; EGR1 protein promotes the reaction [sulindac sulfide results in increased expression of ATF3 mRNA]; MAP2K1 protein promotes the reaction [sulindac sulfide results in increased expression of ATF3 mRNA] sulindac sulfide results in increased expression of ATF3 mRNA; sulindac sulfide results in increased expression of ATF3 protein |
CTD |
PMID:12734198 PMID:15897233 PMID:16079301 PMID:16184548 PMID:21554132 PMID:24440808 More...
|
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atp6v0a1 |
ATPase H+ transporting V0 subunit a1 |
increases expression |
ISO |
sulindac sulfide results in increased expression of ATP6V0A1 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr10:85,935,802...85,989,901
Ensembl chr10:85,935,854...85,989,895
|
|
G |
Aurka |
aurora kinase A |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of AURKA mRNA |
CTD |
PMID:12734198 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Bad |
BCL2-associated agonist of cell death |
decreases expression increases localization multiple interactions |
ISO |
sulindac sulfide results in decreased expression of BAD protein sulindac sulfide results in increased localization of BAD protein [sulindac sulfide results in decreased expression of YWHAE protein] which results in increased localization of BAD protein; sulindac sulfide promotes the reaction [BAD protein binds to YWHAE protein] |
CTD |
PMID:17409426 PMID:18678619 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases response to substance |
EXP |
BAK1 results in increased susceptibility to sulindac sulfide |
CTD |
PMID:18349538 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression decreases expression affects response to substance |
ISO |
BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein]]; BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein]]; BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein]] sulindac sulfide results in increased expression of BAX mRNA sulindac sulfide results in decreased expression of BAX protein BAX protein affects the susceptibility to sulindac sulfide |
CTD |
PMID:12203115 PMID:16886631 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcam |
basal cell adhesion molecule (Lutheran blood group) |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of BCAM mRNA |
CTD |
PMID:12734198 |
|
NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:79,415,017...79,429,403
|
|
G |
Bcar1 |
BCAR1 scaffold protein, Cas family member |
decreases phosphorylation |
ISO |
sulindac sulfide results in decreased phosphorylation of BCAR1 protein |
CTD |
PMID:10741720 |
|
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of BCL2 protein |
CTD |
PMID:18678619 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of BCL2L1 protein |
CTD |
PMID:11912124 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bid |
BH3 interacting domain death agonist |
decreases expression increases cleavage |
ISO |
sulindac sulfide results in decreased expression of BID protein sulindac sulfide results in increased cleavage of BID protein |
CTD |
PMID:12203115 PMID:16886631 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression |
ISO |
sulindac sulfide results in increased expression of BIRC3 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of BUB1B mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
Cacng3 |
calcium voltage-gated channel auxiliary subunit gamma 3 |
increases expression |
ISO |
sulindac sulfide results in increased expression of CACNG3 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 1:177,201,361...177,297,019
Ensembl chr 1:177,201,288...177,297,024
|
|
G |
Casp3 |
caspase 3 |
increases activity increases expression multiple interactions |
ISO |
sulindac sulfide results in increased activity of CASP3 protein sulindac sulfide results in increased expression of CASP3 mRNA [sulindac sulfide co-treated with TNF protein] results in increased activity of CASP3 protein; BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein]]; MAP2K1 protein inhibits the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein]; PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP3 protein]; sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein; tempol inhibits the reaction [[sulindac sulfide co-treated with TNF protein] results in increased activity of CASP3 protein]; TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein] |
CTD |
PMID:11051267 PMID:12203115 PMID:12414664 PMID:14555707 PMID:15548677 PMID:16886631 PMID:20371263 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
[sulindac sulfide co-treated with TNF protein] results in increased activity of CASP7 protein; tempol inhibits the reaction [[sulindac sulfide co-treated with TNF protein] results in increased activity of CASP7 protein] |
CTD |
PMID:20371263 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases activity |
ISO |
BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein]]; PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP8 protein]; sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein; TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein] |
CTD |
PMID:11559570 PMID:12203115 PMID:12414664 PMID:16886631 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity |
ISO |
BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein]]; PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP9 protein]; sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein; TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein] |
CTD |
PMID:12203115 PMID:12414664 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
increases expression |
ISO |
sulindac sulfide results in increased expression of CCAR1 mRNA |
CTD |
PMID:12734198 |
|
NCBI chr20:30,685,916...30,728,531
Ensembl chr20:30,685,916...30,728,526
|
|
G |
Ccn2 |
cellular communication network factor 2 |
decreases expression increases expression |
ISO |
sulindac sulfide results in decreased expression of CCN2 mRNA sulindac sulfide results in increased expression of CCN2 mRNA |
CTD |
PMID:12734198 PMID:16184548 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
ISO |
sulindac sulfide inhibits the reaction [CTNNB1 protein results in increased expression of CCND1 protein] sulindac sulfide results in decreased expression of CCND1 mRNA; sulindac sulfide results in decreased expression of CCND1 protein |
CTD |
PMID:14710233 PMID:15188006 PMID:15767558 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd4 |
Cd4 molecule |
increases expression |
ISO |
sulindac sulfide results in increased expression of CD4 mRNA |
CTD |
PMID:12734198 |
|
NCBI chr 4:157,668,878...157,695,366
|
|
G |
Cd46 |
CD46 molecule |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of CD46 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
sulindac sulfide results in increased expression of and results in increased activity of CDH1 protein |
CTD |
PMID:12391285 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh17 |
cadherin 17 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of CDH17 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 5:25,262,820...25,314,884
Ensembl chr 5:25,262,758...25,314,884
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions affects activity increases expression |
ISO |
PPARD protein inhibits the reaction [sulindac sulfide results in increased expression of CDKN1A mRNA]; PPARG protein promotes the reaction [sulindac sulfide results in increased expression of CDKN1A mRNA] sulindac sulfide affects the activity of CDKN1A protein sulindac sulfide results in increased expression of CDKN1A mRNA; sulindac sulfide results in increased expression of CDKN1A protein |
CTD |
PMID:15694660 PMID:15767558 PMID:16091736 PMID:16184548 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression |
ISO |
sulindac sulfide results in increased expression of CEBPB mRNA; sulindac sulfide results in increased expression of CEBPB protein |
CTD |
PMID:12734198 PMID:16184548 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of CFLAR protein |
CTD |
PMID:11912124 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Clp1 |
cleavage factor polyribonucleotide kinase subunit 1 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of CLP1 mRNA |
CTD |
PMID:12734198 |
|
NCBI chr 3:69,806,774...69,818,633
Ensembl chr 3:69,806,778...69,810,421
|
|
G |
Cryab |
crystallin, alpha B |
increases expression |
ISO |
sulindac sulfide results in increased expression of CRYAB mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions decreases expression |
ISO |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of CTNNB1 protein]; sulindac sulfide affects the localization of and results in decreased expression of CTNNB1 protein; sulindac sulfide inhibits the reaction [CTNNB1 protein results in increased expression of CCND1 protein]; sulindac sulfide inhibits the reaction [CTNNB1 protein results in increased expression of MET protein]; sulindac sulfide results in decreased expression of and results in decreased localization of CTNNB1 protein |
CTD |
PMID:14555707 PMID:14710233 PMID:15188006 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctsc |
cathepsin C |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of CTSC mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
|
|
G |
Cyb5b |
cytochrome b5 type B |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of CYB5B mRNA |
CTD |
PMID:12734198 |
|
NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
sulindac sulfide results in increased expression of CYP1A1 mRNA |
CTD |
PMID:12734198 PMID:16184548 PMID:17985343 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
ISO |
sulindac sulfide results in increased expression of CYP1A2 mRNA |
CTD |
PMID:17985343 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
ISO |
sulindac sulfide results in increased expression of CYP1B1 mRNA |
CTD |
PMID:12734198 PMID:17985343 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Dcbld2 |
discoidin, CUB and LCCL domain containing 2 |
increases expression |
ISO |
sulindac sulfide results in increased expression of DCBLD2 mRNA |
CTD |
PMID:12734198 |
|
NCBI chr11:42,125,525...42,179,927
Ensembl chr11:42,125,787...42,179,697
|
|
G |
Ddx11 |
DEAD/H-box helicase 11 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of DDX11 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 9:105,833,234...105,862,844
Ensembl chr 9:105,833,504...105,862,550
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of DHCR24 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of DHCR7 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of DYNLL1 mRNA |
CTD |
PMID:12734198 |
|
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions decreases expression increases ubiquitination increases phosphorylation decreases phosphorylation |
ISO |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of EGFR protein]; Chloroquine inhibits the reaction [sulindac sulfide results in decreased expression of EGFR protein] sulindac sulfide results in increased ubiquitination of EGFR protein sulindac sulfide results in increased phosphorylation of EGFR protein sulindac sulfide results in decreased phosphorylation of EGFR protein |
CTD |
PMID:20332299 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions increases expression |
ISO |
EGR1 protein affects the reaction [sulindac sulfide results in increased expression of THBS1 mRNA]; EGR1 protein promotes the reaction [sulindac sulfide results in increased expression of ATF3 mRNA]; EGR1 protein promotes the reaction [sulindac sulfide results in increased expression of GDF15 mRNA]; ELK1 protein promotes the reaction [sulindac sulfide results in increased expression of EGR1 mRNA]; MAPK1 protein promotes the reaction [sulindac sulfide results in increased expression of EGR1 mRNA]; MAPK3 protein promotes the reaction [sulindac sulfide results in increased expression of EGR1 mRNA]; U 0126 inhibits the reaction [sulindac sulfide results in increased expression of EGR1 mRNA] sulindac sulfide results in increased expression of EGR1 mRNA; sulindac sulfide results in increased expression of EGR1 protein |
CTD |
PMID:15509713 PMID:16079301 PMID:16227405 PMID:17599376 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
multiple interactions |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein]; ELK1 protein promotes the reaction [sulindac sulfide results in increased expression of EGR1 mRNA]; MAPK1 protein promotes the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein]; MAPK3 protein promotes the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein]; sulindac sulfide results in increased phosphorylation of and affects the activity of ELK1 protein; U 0126 inhibits the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein] |
CTD |
PMID:17599376 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions decreases expression |
ISO |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of ERBB2 protein] |
CTD |
PMID:20332299 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
multiple interactions decreases expression |
ISO |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of ERBB3 protein] |
CTD |
PMID:20332299 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
affects cleavage |
ISO |
sulindac sulfide affects the cleavage of ERBB4 protein |
CTD |
PMID:12777371 |
|
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Esd |
esterase D |
increases expression |
ISO |
sulindac sulfide results in increased expression of ESD mRNA |
CTD |
PMID:12734198 |
|
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of ESR1 mRNA; sulindac sulfide results in decreased expression of ESR1 protein |
CTD |
PMID:16740773 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Etfb |
electron transfer flavoprotein subunit beta |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of ETFB mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 1:93,851,908...93,866,072
Ensembl chr 1:93,851,858...93,866,068
|
|
G |
Etnppl |
ethanolamine-phosphate phospho-lyase |
increases expression |
ISO |
sulindac sulfide results in increased expression of ETNPPL mRNA |
CTD |
PMID:12734198 |
|
NCBI chr 2:219,173,048...219,194,646
Ensembl chr 2:219,172,978...219,192,212
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
multiple interactions increases expression |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [sulindac sulfide analog results in increased expression of FABP1 protein]; PPARG protein affects the reaction [sulindac sulfide analog results in increased expression of FABP1 protein] |
CTD |
PMID:17602619 PMID:18665581 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions increases expression |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [sulindac sulfide analog results in increased expression of FABP4 protein]; PPARG protein affects the reaction [sulindac sulfide analog results in increased expression of FABP4 protein] |
CTD |
PMID:17602619 PMID:18665581 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fcgrt |
Fc gamma receptor and transporter |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of FCGRT mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 1:95,574,436...95,584,171
Ensembl chr 1:95,567,175...95,584,084
|
|
G |
Fdps |
farnesyl diphosphate synthase |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of FDPS mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of FGFR4 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
affects metabolic processing increases metabolic processing |
ISO |
FMO3 gene polymorphism affects the metabolism of sulindac sulfide FMO3 protein results in increased metabolism of sulindac sulfide |
CTD |
PMID:17142560 PMID:17559352 |
|
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of FOXM1 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Gal3st4 |
galactose-3-O-sulfotransferase 4 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of GAL3ST4 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr12:17,267,963...17,276,951
Ensembl chr12:17,267,963...17,276,833
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
increases expression |
ISO |
sulindac sulfide results in increased expression of GARS1 mRNA |
CTD |
PMID:12734198 |
|
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
|
|
G |
Gdf15 |
growth differentiation factor 15 |
multiple interactions increases expression |
ISO |
EGR1 protein promotes the reaction [sulindac sulfide results in increased expression of GDF15 mRNA] sulindac sulfide results in increased expression of GDF15 mRNA; sulindac sulfide results in increased expression of GDF15 protein |
CTD |
PMID:11895857 PMID:11925476 PMID:12734198 PMID:15180942 PMID:15509713 PMID:15555568 PMID:15767558 PMID:18076062 More...
|
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gk |
glycerol kinase |
increases expression |
ISO |
sulindac sulfide results in increased expression of GK mRNA |
CTD |
PMID:16184548 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Glcci1 |
glucocorticoid induced 1 |
increases expression |
ISO |
sulindac sulfide results in increased expression of GLCCI1 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 4:36,307,956...36,635,614
Ensembl chr 4:36,307,903...36,635,612
|
|
G |
Grn |
granulin precursor |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of GRN mRNA |
CTD |
PMID:16184548 |
|
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
sulindac sulfide binds to and results in decreased activity of GSTP1 protein |
CTD |
PMID:15300575 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hdac1 |
histone deacetylase 1 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of HDAC1 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hgf |
hepatocyte growth factor |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of HGF mRNA |
CTD |
PMID:10807402 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hm13 |
histocompatibility minor 13 |
affects binding multiple interactions |
ISO |
sulindac sulfide binds to HM13 protein sulindac sulfide inhibits the reaction [L 685458 binds to HM13 protein] |
CTD |
PMID:17932033 |
|
NCBI chr 3:141,145,792...141,183,557
Ensembl chr 3:141,145,782...141,184,703
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
ISO |
sulindac sulfide results in increased expression of HSPA1B mRNA |
CTD |
PMID:16184548 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression |
ISO |
sulindac sulfide results in increased expression of HSPA6 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Icam2 |
intercellular adhesion molecule 2 |
increases expression |
ISO |
sulindac sulfide results in increased expression of ICAM2 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr10:91,308,608...91,319,536
Ensembl chr10:91,308,538...91,315,293
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of ID1 mRNA; sulindac sulfide results in decreased expression of ID1 protein |
CTD |
PMID:16184548 PMID:21554132 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of IFITM1 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
decreases expression |
ISO |
sulindac sulfide results in decreased expression of IFITM3 mRNA |
CTD |
PMID:16184548 |
|
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
increases expression |
ISO |
sulindac sulfide results in increased expression of IFRD1 mRNA |
CTD |
PMID:12734198 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
decreases activity |
ISO |
sulindac sulfide results in decreased activity of IKBKB protein |
CTD |
| |